Treatment of Childhood Pneumonia in Developing Countries by Hasan Ashraf et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Treatment of childhood pneumonia in developing countries 59
Treatment of childhood pneumonia in developing countries
Hasan Ashraf, Mohammod Jobayer Chisti and Nur Haque Alam
X 
 
Treatment of childhood pneumonia  
in developing countries 
 
Hasan Ashraf, Mohammod Jobayer Chisti and Nur Haque Alam 
Clinical Sciences Division, International Centre for Diarrhoeal Disease Research, 
Bangladesh (ICDDR,B) 
Bangladesh 
 
Introduction 
Definition of community acquired pneumonia (CAP) 
CAP can be defined clinically as the presence of signs and symptoms of pneumonia in a 
previously healthy child due to an acute infection (of less than 14 days’ duration) of the 
lower respiratory tract (usually occurs below terminal bronchioles) leading to cough or 
difficult breathing, tachypnoea, or lower chest-wall indrawing, which has been acquired in 
the community outside hospital (Zar et al., 2005; BTS, 2002). In developed countries this can 
be verified by the radiological finding of consolidation (BTS, 2002). In resource poor setting 
of the developing world, a more practical term - acute lower respiratory infection (ALRI) - is 
preferred, reflecting the difficulties in obtaining a chest radiograph, especially in rural areas 
(BTS, 2002).  
 
Disease burden and epidemiology of CAP 
In the developing world, pneumonia is not only more common than it is in Europe and 
North America (Riley et al.,1983; Berman & McIntosh, 1985; Selwyn, 1990), but also more 
severe and is the largest killer disease of children (Bulla & Hitze, 1978; Baqui et al., 1998). 
The fourth Millennium Development Goal has concentrated efforts on addressing the 
priority areas for improving child survival worldwide, with an aim of reducing the national 
child mortality rates by two-thirds by 2015 (UN, 2000). ALRI, particularly pneumonia, are 
currently the leading and biggest single cause of deaths among under-5 children 1 to 59 
months of age in the developing countries (UNICEF & WHO, 2006; Graham et al., 2008), 
being responsible for at least 19% of the annual 8.8 million deaths in this age-group 
(Wardlaw et al., 2006). ALRI causes more than 2 million child deaths (one million in children 
aged 1 to 59 months and additional one million in neonates) worldwide each year, mostly 
from pneumonia, accounting for 20% of deaths in under-5 children (Bryce et al., 2005; Rudan 
et al., 2004), and 90-95% of all these deaths occur in the developing countries (Rudan et al., 
2008; Murray & Lopez, 1997; Garenne et al., 1992; Mulholland, 1999; Williams et al., 2002; 
WHO, 1998). In terms of magnitude of the problem, there is an estimated incidence of 151 
million new cases of pneumonia each year globally, and 11-20 million (7-13%) are severe 
enough to require hospitalization in the developing countries (Rudan et al., 2004; Rudan et 
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al., 2008). Recent estimates also suggest that 1.9 million (95% CI 1.6 to 2.2 million) children 
died from acute respiratory infection (ARI) throughout the world in 2000 and 70% of them 
occurred in Africa and Southeast Asia, one dying in every 7 seconds (Mulholland, 1999; 
Williams et al., 2002). Actually, CAP is a major cause of health care utilization, 
hospitalization, and death in children in the developing countries (Mulholland, 1999; 
Williams et al., 2002; WHO, 1998). Therefore, improvement in the case-management 
strategies of the major causes of child death, such as pneumonia and neonatal illnesses in 
developing countries, should be a priority in improving the child survival in the developing 
countries (Walley et al., 2008; Duke & Tamburlini, 2003). ARI is also a major cause of visits 
to the outpatient and emergency departments as well as admissions to the hospitals. 
Although bronchiolitis, tracheobronchitis and pneumonia, each accounts for one-third of 
ALRI cases, pneumonia is responsible for most of the ALRI deaths. In Bangladesh, ALRI 
account for 25% of deaths among under-5 children and constitute 40% of all infantile deaths 
(Baqui et al., 1998). In a study conducted at the Dhaka Hospital of ICDDR,B among 401 
under-5 children with ALRI, it was observed that the most common manifestation was 
pneumonia and a respiratory pathogen (both bacterial and viral) was identified in 30% cases 
and the case fatality rates were 14% in bacterial pneumonia and 3% in viral pneumonia 
(Rahman et al., 1990). In another study also conducted at the Dhaka Hospital of ICDDR,B 
among 601 under-5 children with ALRI, it was observed that the most common 
manifestation was pneumonia (86.5%), and a viral pathogen was detected in 21% cases, and 
the overall case fatality rate was 6.8%, and that of viral pneumonia was 4.8% (Huq et al., 1990). 
 
Objective 
To develop guidelines for the physicians and nurses of the developing countries for the 
diagnosis and management of CAP in children 
 
Options 
 Clinical assessment 
 Radiographic assessment 
 Laboratory testing 
 Empirical antimicrobial therapy 
 
Outcomes 
 Increased awareness of the age-related causes of CAP including those children 
with severe acute malnutrition (SAM), and those with dehydrating diarrhoea 
 Improved accuracy of clinical diagnosis of CAP in children 
 Better utilization of the available diagnostic testing 
 Rational use of empirical antimicrobial therapy  
 Decreased morbidity and mortality due to CAP 
 
Benefits, harms, and costs 
 Increased awareness of the causes of paediatric pneumonia 
 Accurate diagnosis 
 Prompt treatment 
 Reduced cost associated with unnecessary investigations and complications due to 
inappropriate treatment 
 
Rationale 
As pneumonia is a major cause of morbidity and mortality in children in the developing 
countries (Williams et al., 2002), early and appropriate treatment of pneumonia can reduce 
the morbidity and mortality (Sazawal & Black, 2003), which has been the rationale for the 
development of guidelines for the management of CAP (Zar et al., 2005). The guidelines also 
aim to provide recommendations for effective therapy and to minimize the development of 
bacterial resistance through judicious use of antibiotics (Zar et al., 2005). This document 
aims to provide guidelines for the diagnosis and effective management of children with 
CAP so as to improve pneumonia-associated morbidity and mortality, thereby improving 
the case-management strategies of the major cause of child death, such as pneumonia in the 
developing countries which should be a priority in improving child survival globally 
(Walley et al., 2008; Duke & Tamburlini, 2003).  
 
Clinical classification and management plan of CAP 
Depending on the clinical presentation, pneumonia can be classified as very severe, severe, 
or non-severe according to the World Health Organization (WHO) (WHO, 1990; WHO, 
1984; WHO, 2000; WHO, 1991). The specific treatment guidelines for each of them, and the 
diagnosis of pneumonia should primarily be based on the visible clinical parameters, 
including respiratory rate and lower chest-wall indrawing (WHO, 1990; WHO, 1991; Cashat 
et al., 2005). Pneumonia is usually caused by viruses or bacteria, but the most serious 
episodes are caused by bacteria. However, in the absence of clear cut demarcation for 
aetiological diagnosis of pneumonia on the basis of clinical and/or radiological features, 
empiric antibiotic therapy is needed for all cases of CAP. Hospitalization of children with 
severe pneumonia is recommended for giving supportive treatment including 
oropharyngeal or nasopharyngeal suction, oxygen therapy for hypoxaemia, fluid and 
nutritional management, and close monitoring (WHO, 1990; WHO, 1984; WHO, 2000; WHO, 
1991). Therefore, management of severe childhood pneumonia relies on hospital-based 
treatment, but practical barriers often prevent children in areas with highest rates from 
receiving hospital care (Ashraf et al., 2008). In the developing countries, there are not 
enough paediatric beds in hospitals for admission of all severe cases of pneumonia (Ashraf 
et al. 2008). In addition, hospitalization may not be possible because of the inability of the 
parents to visit the hospital because of the long distances to travel or financial or other 
domestic reasons, such as the need to care for siblings at home and the need for the mother 
to work (Ashraf et al., 2008; Ashraf et al., 2007). It is, therefore, important to provide some 
form of institutional care for children who cannot be hospitalized, at least until stabilization 
of their acute condition (Ashraf et al., 2008). Radiological examination and determination of 
hypoxaemia by pulse oximetry, have been recently considered as the optimal methods for 
diagnosing pneumonia. But, they are clearly suitable only for use in the institutional settings 
like the day-care centres or out-patient clinics. Two prospective observational studies have 
shown that the day-care facility-based, modified primary care management of severe 
childhood pneumonia (Ashraf et al., 2008) and severe acute malnutrition (SAM) (Ashraf et 
al., 2007) is successful and cost-effective as an alternative to hospitalization. Provision of 
broad-spectrum antibiotics and appropriate supportive care during a stay at established 
day-care centre during their working hours, followed by the continuation of care at home at 
night, is an effective alternative to hospitalization of children with severe pneumonia 
without associated co-morbidities such as SAM (Ashraf et al., 2008). The results of this study 
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al., 2008). Recent estimates also suggest that 1.9 million (95% CI 1.6 to 2.2 million) children 
died from acute respiratory infection (ARI) throughout the world in 2000 and 70% of them 
occurred in Africa and Southeast Asia, one dying in every 7 seconds (Mulholland, 1999; 
Williams et al., 2002). Actually, CAP is a major cause of health care utilization, 
hospitalization, and death in children in the developing countries (Mulholland, 1999; 
Williams et al., 2002; WHO, 1998). Therefore, improvement in the case-management 
strategies of the major causes of child death, such as pneumonia and neonatal illnesses in 
developing countries, should be a priority in improving the child survival in the developing 
countries (Walley et al., 2008; Duke & Tamburlini, 2003). ARI is also a major cause of visits 
to the outpatient and emergency departments as well as admissions to the hospitals. 
Although bronchiolitis, tracheobronchitis and pneumonia, each accounts for one-third of 
ALRI cases, pneumonia is responsible for most of the ALRI deaths. In Bangladesh, ALRI 
account for 25% of deaths among under-5 children and constitute 40% of all infantile deaths 
(Baqui et al., 1998). In a study conducted at the Dhaka Hospital of ICDDR,B among 401 
under-5 children with ALRI, it was observed that the most common manifestation was 
pneumonia and a respiratory pathogen (both bacterial and viral) was identified in 30% cases 
and the case fatality rates were 14% in bacterial pneumonia and 3% in viral pneumonia 
(Rahman et al., 1990). In another study also conducted at the Dhaka Hospital of ICDDR,B 
among 601 under-5 children with ALRI, it was observed that the most common 
manifestation was pneumonia (86.5%), and a viral pathogen was detected in 21% cases, and 
the overall case fatality rate was 6.8%, and that of viral pneumonia was 4.8% (Huq et al., 1990). 
 
Objective 
To develop guidelines for the physicians and nurses of the developing countries for the 
diagnosis and management of CAP in children 
 
Options 
 Clinical assessment 
 Radiographic assessment 
 Laboratory testing 
 Empirical antimicrobial therapy 
 
Outcomes 
 Increased awareness of the age-related causes of CAP including those children 
with severe acute malnutrition (SAM), and those with dehydrating diarrhoea 
 Improved accuracy of clinical diagnosis of CAP in children 
 Better utilization of the available diagnostic testing 
 Rational use of empirical antimicrobial therapy  
 Decreased morbidity and mortality due to CAP 
 
Benefits, harms, and costs 
 Increased awareness of the causes of paediatric pneumonia 
 Accurate diagnosis 
 Prompt treatment 
 Reduced cost associated with unnecessary investigations and complications due to 
inappropriate treatment 
 
Rationale 
As pneumonia is a major cause of morbidity and mortality in children in the developing 
countries (Williams et al., 2002), early and appropriate treatment of pneumonia can reduce 
the morbidity and mortality (Sazawal & Black, 2003), which has been the rationale for the 
development of guidelines for the management of CAP (Zar et al., 2005). The guidelines also 
aim to provide recommendations for effective therapy and to minimize the development of 
bacterial resistance through judicious use of antibiotics (Zar et al., 2005). This document 
aims to provide guidelines for the diagnosis and effective management of children with 
CAP so as to improve pneumonia-associated morbidity and mortality, thereby improving 
the case-management strategies of the major cause of child death, such as pneumonia in the 
developing countries which should be a priority in improving child survival globally 
(Walley et al., 2008; Duke & Tamburlini, 2003).  
 
Clinical classification and management plan of CAP 
Depending on the clinical presentation, pneumonia can be classified as very severe, severe, 
or non-severe according to the World Health Organization (WHO) (WHO, 1990; WHO, 
1984; WHO, 2000; WHO, 1991). The specific treatment guidelines for each of them, and the 
diagnosis of pneumonia should primarily be based on the visible clinical parameters, 
including respiratory rate and lower chest-wall indrawing (WHO, 1990; WHO, 1991; Cashat 
et al., 2005). Pneumonia is usually caused by viruses or bacteria, but the most serious 
episodes are caused by bacteria. However, in the absence of clear cut demarcation for 
aetiological diagnosis of pneumonia on the basis of clinical and/or radiological features, 
empiric antibiotic therapy is needed for all cases of CAP. Hospitalization of children with 
severe pneumonia is recommended for giving supportive treatment including 
oropharyngeal or nasopharyngeal suction, oxygen therapy for hypoxaemia, fluid and 
nutritional management, and close monitoring (WHO, 1990; WHO, 1984; WHO, 2000; WHO, 
1991). Therefore, management of severe childhood pneumonia relies on hospital-based 
treatment, but practical barriers often prevent children in areas with highest rates from 
receiving hospital care (Ashraf et al., 2008). In the developing countries, there are not 
enough paediatric beds in hospitals for admission of all severe cases of pneumonia (Ashraf 
et al. 2008). In addition, hospitalization may not be possible because of the inability of the 
parents to visit the hospital because of the long distances to travel or financial or other 
domestic reasons, such as the need to care for siblings at home and the need for the mother 
to work (Ashraf et al., 2008; Ashraf et al., 2007). It is, therefore, important to provide some 
form of institutional care for children who cannot be hospitalized, at least until stabilization 
of their acute condition (Ashraf et al., 2008). Radiological examination and determination of 
hypoxaemia by pulse oximetry, have been recently considered as the optimal methods for 
diagnosing pneumonia. But, they are clearly suitable only for use in the institutional settings 
like the day-care centres or out-patient clinics. Two prospective observational studies have 
shown that the day-care facility-based, modified primary care management of severe 
childhood pneumonia (Ashraf et al., 2008) and severe acute malnutrition (SAM) (Ashraf et 
al., 2007) is successful and cost-effective as an alternative to hospitalization. Provision of 
broad-spectrum antibiotics and appropriate supportive care during a stay at established 
day-care centre during their working hours, followed by the continuation of care at home at 
night, is an effective alternative to hospitalization of children with severe pneumonia 
without associated co-morbidities such as SAM (Ashraf et al., 2008). The results of this study 
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indicate that severe childhood pneumonia without SAM can be successfully managed on a 
day-care basis at established day-care clinics, if adequately trained and motivated staff and 
the necessary logistic support can be made available (Ashraf et al., 2008). The results of a 
randomized controlled clinical trial (RCT) have shown that in a select group of under-5 
children with severe pneumonia, without associated co-morbidities such as SAM, can be 
safely and effectively managed on a day-care basis as effectively as the hospital set-up 
management, except those children with hypoxaemia requiring prolonged oxygen therapy 
for more than six hours, and that day-care based treatment option is less expensive than 
hospital-care (Ashraf et al., 2010). The results also indicate that severe pneumonia without 
hypoxaemia can be successfully managed on a day-care basis at a day-care clinic, however, 
identification of those severely pneumonic children having hypoxaemia requiring 
prolonged oxygen therapy for more than six hours are necessary, as they are at increased 
risk of death and therefore need to be hospitalized for support and care for a longer period 
of time (Ashraf et al., 2010). These results would have great impact in the treatment and care 
of childhood pneumonia, particularly in resource-poor countries where hospital beds are 
scarce. It can be easily replicated in most urban and rural out-patient clinics and day-care 
centres, provided that proper training and motivation of the staff as well as provision of 
logistic support are guaranteed. The additionally needed funds are well invested facing the 
lower costs of the day-care treatment model compared to those of hospital-care (US$ 114 vs. 
178) (Ashraf et al., 2010). However, policy and programme changes would be necessary to 
add such components to the out-patient clinics and day-care centres, and this would require 
additional human and financial resources, which is not an easy task. Therefore, this would 
be important in selecting the intervention for wider implementation in national 
programmes. The results of our RCT identified a way to more efficiently use scarce hospital 
beds in developing countries by selecting out children with severe pneumonia for the day-
care management, who following existing guidelines, would have been identified as the 
ones requiring hospitalization. This would be a practical approach in developing countries - 
a smaller investment in upgrading the day-care facilities through development of trained 
resources and procurement of some supporting equipment, which could pay back in a much 
greater way. 
 
Rapid/fast breathing (WHO) 
Rapid/fast breathing is defined as when the age-specific respiratory rates become 
≥60/minute in neonates and infants aged <2 months, ≥50/minute in infants aged 2 to <12 
months, and  ≥40/minute in children aged 12-59 months, as shown below: 
 
●   Age < 2 months:  60/minute    
●   Age 2 to <12 months:  50/minute    
●   Age 12 months-5 years:  40/minute  
 
(N. B.  A child who is exactly 12 months old would have fast breathing if s/he breaths  
40/minute.  Tachypnoea is the best single predictor of pneumonia in children of all ages). 
 
Lower chest-wall indrawing 
Indrawing of the chest wall is a manifestation of reduced lung compliance resulting from 
the tendency of declining intra-alveolar pressure due to pneumonic consolidation or 
airways obstruction. WHO recommends the use of lower chest wall indrawing as a sign of 
pneumonia requiring admission to hospital, defined as the inward movement of the bony 
structures of the lower chest wall with inspiration. Lower chest-wall indrawing is also called 
“subcostal indrawing”/“subcostal retractions” 
 
Clinical types of pneumonia (WHO)  
● Very severe pneumonia (up to 5 years)     
● Severe pneumonia (up to 5 years) 
● Pneumonia (not severe) (only for children aged 2 months to 5 years)   
● No pneumonia: cough or cold (up to 5 years) 
 
Very severe pneumonia 
If a child with cough or difficult breathing has any one or more of the following danger 
signs, s/he is classified as having very severe pneumonia (WHO, 2005) 
 
● Not able to drink    
● Cyanosis    
● Head nodding  
 
“No danger signs” are defined as the absence of all of the following danger signs: not able to 
drink/feed, central cyanosis, head nodding, stridor in calm child, abnormally sleepy, 
convulsion, and severe clinical malnutrition. 
 
If a child presents with severe malnutrition with any sign of pneumonia (any of the WHO 
defined signs of pneumonia or severe pneumonia or very severe pneumonia or crackles or 
bronchial breath sound in lungs or radiological pneumonia) should be considered as very 
severe pneumonia. 
 
Severe pneumonia 
Severe pneumonia is defined as an young infant (< 2 months ) with cough or difficult 
breathing having fast breathing and/or lower chest-wall indrawing, or a child (2 months to 
5 years) with cough or difficult breathing having only lower chest-wall indrawing. 
 
Pneumonia (not severe) 
Pneumonia (not severe) is defined as a child (2 months to 5 years) with cough or difficult 
breathing having only fast breathing, but no lower chest-wall indrawing, or no signs of very 
severe pneumonia.  
 
Aetiology of CAP 
Rational treatment for pneumonia depends on knowing the most likely pathogens in each 
community, as the relative frequency of different agents may vary from one geographical 
region to another and depends on the age of the patient, vaccination status, immunological 
status, relevant exposure and clinical setting at which pneumonia was acquired. Mixed 
bacterial and viral infections may occur in 30-40% of cases of CAP (Zar et al., 2005). 
Streptococcus pneumoniae is the most common bacterial cause of childhood pneumonia (BTS, 
2002)), followed by Haemophilus influenzae, Mycoplasma pneumoniae, Chlamydia pneumoniae, 
and Mycobacterium tuberculosis.  The less common bacterial causes are Staphylococcus aureus, 
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indicate that severe childhood pneumonia without SAM can be successfully managed on a 
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hospital-care (Ashraf et al., 2010). The results also indicate that severe pneumonia without 
hypoxaemia can be successfully managed on a day-care basis at a day-care clinic, however, 
identification of those severely pneumonic children having hypoxaemia requiring 
prolonged oxygen therapy for more than six hours are necessary, as they are at increased 
risk of death and therefore need to be hospitalized for support and care for a longer period 
of time (Ashraf et al., 2010). These results would have great impact in the treatment and care 
of childhood pneumonia, particularly in resource-poor countries where hospital beds are 
scarce. It can be easily replicated in most urban and rural out-patient clinics and day-care 
centres, provided that proper training and motivation of the staff as well as provision of 
logistic support are guaranteed. The additionally needed funds are well invested facing the 
lower costs of the day-care treatment model compared to those of hospital-care (US$ 114 vs. 
178) (Ashraf et al., 2010). However, policy and programme changes would be necessary to 
add such components to the out-patient clinics and day-care centres, and this would require 
additional human and financial resources, which is not an easy task. Therefore, this would 
be important in selecting the intervention for wider implementation in national 
programmes. The results of our RCT identified a way to more efficiently use scarce hospital 
beds in developing countries by selecting out children with severe pneumonia for the day-
care management, who following existing guidelines, would have been identified as the 
ones requiring hospitalization. This would be a practical approach in developing countries - 
a smaller investment in upgrading the day-care facilities through development of trained 
resources and procurement of some supporting equipment, which could pay back in a much 
greater way. 
 
Rapid/fast breathing (WHO) 
Rapid/fast breathing is defined as when the age-specific respiratory rates become 
≥60/minute in neonates and infants aged <2 months, ≥50/minute in infants aged 2 to <12 
months, and  ≥40/minute in children aged 12-59 months, as shown below: 
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●   Age 2 to <12 months:  50/minute    
●   Age 12 months-5 years:  40/minute  
 
(N. B.  A child who is exactly 12 months old would have fast breathing if s/he breaths  
40/minute.  Tachypnoea is the best single predictor of pneumonia in children of all ages). 
 
Lower chest-wall indrawing 
Indrawing of the chest wall is a manifestation of reduced lung compliance resulting from 
the tendency of declining intra-alveolar pressure due to pneumonic consolidation or 
airways obstruction. WHO recommends the use of lower chest wall indrawing as a sign of 
pneumonia requiring admission to hospital, defined as the inward movement of the bony 
structures of the lower chest wall with inspiration. Lower chest-wall indrawing is also called 
“subcostal indrawing”/“subcostal retractions” 
 
Clinical types of pneumonia (WHO)  
● Very severe pneumonia (up to 5 years)     
● Severe pneumonia (up to 5 years) 
● Pneumonia (not severe) (only for children aged 2 months to 5 years)   
● No pneumonia: cough or cold (up to 5 years) 
 
Very severe pneumonia 
If a child with cough or difficult breathing has any one or more of the following danger 
signs, s/he is classified as having very severe pneumonia (WHO, 2005) 
 
● Not able to drink    
● Cyanosis    
● Head nodding  
 
“No danger signs” are defined as the absence of all of the following danger signs: not able to 
drink/feed, central cyanosis, head nodding, stridor in calm child, abnormally sleepy, 
convulsion, and severe clinical malnutrition. 
 
If a child presents with severe malnutrition with any sign of pneumonia (any of the WHO 
defined signs of pneumonia or severe pneumonia or very severe pneumonia or crackles or 
bronchial breath sound in lungs or radiological pneumonia) should be considered as very 
severe pneumonia. 
 
Severe pneumonia 
Severe pneumonia is defined as an young infant (< 2 months ) with cough or difficult 
breathing having fast breathing and/or lower chest-wall indrawing, or a child (2 months to 
5 years) with cough or difficult breathing having only lower chest-wall indrawing. 
 
Pneumonia (not severe) 
Pneumonia (not severe) is defined as a child (2 months to 5 years) with cough or difficult 
breathing having only fast breathing, but no lower chest-wall indrawing, or no signs of very 
severe pneumonia.  
 
Aetiology of CAP 
Rational treatment for pneumonia depends on knowing the most likely pathogens in each 
community, as the relative frequency of different agents may vary from one geographical 
region to another and depends on the age of the patient, vaccination status, immunological 
status, relevant exposure and clinical setting at which pneumonia was acquired. Mixed 
bacterial and viral infections may occur in 30-40% of cases of CAP (Zar et al., 2005). 
Streptococcus pneumoniae is the most common bacterial cause of childhood pneumonia (BTS, 
2002)), followed by Haemophilus influenzae, Mycoplasma pneumoniae, Chlamydia pneumoniae, 
and Mycobacterium tuberculosis.  The less common bacterial causes are Staphylococcus aureus, 
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Bordetella pertussis, Pneumocystis jiroveci (previously known as Pneumocystis carinii), and 
Niserria meningitidis. In older children, when a bacterial cause is found, it is most commonly 
Streptococcus pneumoniae followed by Mycoplasma and Chlamydia (BTS, 2002). Viruses are the 
most common causes of pneumonia in younger children (infancy, pre-school and school age 
children), except neonates (BTS, 2002). In neonates, the most common causes are Group B 
streptococcus beta haemolyticus (GBB), Escherichia coli,  Klebsiella pneumoniae, Chlamydia 
trachomatis (3-19 weeks), Cytomegalovirus (CMV), and the less common causes are 
Staphylococcus aureus, Listeria monocytogenes, and Pseudomonas. The common viruses are 
Respiratory Syncytial Virus (RSV), influenza, and parainfluenza viruses, adenovirus, and 
human metapneumovirus (HMV).  
 
The spectrum and frequency of causative agents of bacterial pneumonia in severely 
malnourished children often differs in pneumonic children without severe malnutrition 
(Chisti et al., 2009). 
 
Table 1. Causes of CAP according to various age groups and SAM 
 
All age groups 
Bacteria are the major causes of CAP in children 
 
1. Streptococcus pneumoniae: commonest 
2. Haemophilus influenzae (including Hib & nontypable strains) 
3. Staphylococcus aureus 
Atypical bacteria* 
4. Mycoplasma pneumoniae* (> 5 years) 
5. Chlamydia pneumoniae* 
6. Chlamydia trachomatis* (3-19 weeks) 
7. Moraxella catarrhalis 
Gram-negative bacteria** 
8. Klebsiella pneumoniae**  
9. Escherichia coli** 
10. Pseudomonas** 
Viruses*** 
11. Respiratory syncytial virus (RSV)***    
12. Influenza A or B***          
13. Parainfluenza virus types 1, 3***      
14. Adenovirus***    
15. Human metapneumovirus (HMV)***      
16. Rhinovirus*** 
17. Coronavirus*** 
18. Enterovirus*** 
19. CMV*** 
20. Pneumocystis jiroveci (previously known as Pneumocystis carinii) 
 
 
 
 
0-2 months 
1. Group B streptococcus 
Gram-negative bacteria** 
2. Klebsiella pneumoniae** 
3. Escherichia coli** 
4. Pseudomonas** 
5. Staphylococcus aureus 
6. Chlamydia trachomatis* 
7. Listeria monocytogenes 
8. Viruses*** 
9. Ureaplasma urealyticum 
10. Bordetella pertussis 
 
2 months-5 years 
1. Viruses*** 
2. Streptococcus pneumoniae 
3. Haemophilus influenzae (including Hib & nontypable strains) (Common in developing 
countries where vaccination is still not widely used) 
4. Staphylococcus aureus 
5. Mycoplasma pneumoniae* 
 
Above 5 years 
1. Streptococcus pneumoniae 
2. Haemophilus influenzae (including Hib & nontypable strains) 
3. Staphylococcus aureus 
Atypical bacteria* 
4. Mycoplasma pneumoniae* 
5. Chlamydia pneumoniae* 
6. Viruses*** 
 
SAM 
1. Klebsiella pneumonia** (26%) 
2. Staphylococcus aureus (25%) 
3. Streptococcus pneumoniae (18%) 
4. Escherichia coli** (8%) 
5. Haemophilus influenzae (including Hib) (8%) 
6. Salmonella species** 
7. Pseudomonas** 
8. Acinetobacter species** 
9. Methicillin-resistant Staphylococcus aureus (MRSA) 
10. Pneumocystis jiroveci (previously known Pneumocystis carinii) 
11. CMV*** 
12. Candida 
 
(N.B. * indicates atypical bacteria ** indicates gram-negative bacteria *** 
indicates viruses) 
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Bordetella pertussis, Pneumocystis jiroveci (previously known as Pneumocystis carinii), and 
Niserria meningitidis. In older children, when a bacterial cause is found, it is most commonly 
Streptococcus pneumoniae followed by Mycoplasma and Chlamydia (BTS, 2002). Viruses are the 
most common causes of pneumonia in younger children (infancy, pre-school and school age 
children), except neonates (BTS, 2002). In neonates, the most common causes are Group B 
streptococcus beta haemolyticus (GBB), Escherichia coli,  Klebsiella pneumoniae, Chlamydia 
trachomatis (3-19 weeks), Cytomegalovirus (CMV), and the less common causes are 
Staphylococcus aureus, Listeria monocytogenes, and Pseudomonas. The common viruses are 
Respiratory Syncytial Virus (RSV), influenza, and parainfluenza viruses, adenovirus, and 
human metapneumovirus (HMV).  
 
The spectrum and frequency of causative agents of bacterial pneumonia in severely 
malnourished children often differs in pneumonic children without severe malnutrition 
(Chisti et al., 2009). 
 
Table 1. Causes of CAP according to various age groups and SAM 
 
All age groups 
Bacteria are the major causes of CAP in children 
 
1. Streptococcus pneumoniae: commonest 
2. Haemophilus influenzae (including Hib & nontypable strains) 
3. Staphylococcus aureus 
Atypical bacteria* 
4. Mycoplasma pneumoniae* (> 5 years) 
5. Chlamydia pneumoniae* 
6. Chlamydia trachomatis* (3-19 weeks) 
7. Moraxella catarrhalis 
Gram-negative bacteria** 
8. Klebsiella pneumoniae**  
9. Escherichia coli** 
10. Pseudomonas** 
Viruses*** 
11. Respiratory syncytial virus (RSV)***    
12. Influenza A or B***          
13. Parainfluenza virus types 1, 3***      
14. Adenovirus***    
15. Human metapneumovirus (HMV)***      
16. Rhinovirus*** 
17. Coronavirus*** 
18. Enterovirus*** 
19. CMV*** 
20. Pneumocystis jiroveci (previously known as Pneumocystis carinii) 
 
 
 
 
0-2 months 
1. Group B streptococcus 
Gram-negative bacteria** 
2. Klebsiella pneumoniae** 
3. Escherichia coli** 
4. Pseudomonas** 
5. Staphylococcus aureus 
6. Chlamydia trachomatis* 
7. Listeria monocytogenes 
8. Viruses*** 
9. Ureaplasma urealyticum 
10. Bordetella pertussis 
 
2 months-5 years 
1. Viruses*** 
2. Streptococcus pneumoniae 
3. Haemophilus influenzae (including Hib & nontypable strains) (Common in developing 
countries where vaccination is still not widely used) 
4. Staphylococcus aureus 
5. Mycoplasma pneumoniae* 
 
Above 5 years 
1. Streptococcus pneumoniae 
2. Haemophilus influenzae (including Hib & nontypable strains) 
3. Staphylococcus aureus 
Atypical bacteria* 
4. Mycoplasma pneumoniae* 
5. Chlamydia pneumoniae* 
6. Viruses*** 
 
SAM 
1. Klebsiella pneumonia** (26%) 
2. Staphylococcus aureus (25%) 
3. Streptococcus pneumoniae (18%) 
4. Escherichia coli** (8%) 
5. Haemophilus influenzae (including Hib) (8%) 
6. Salmonella species** 
7. Pseudomonas** 
8. Acinetobacter species** 
9. Methicillin-resistant Staphylococcus aureus (MRSA) 
10. Pneumocystis jiroveci (previously known Pneumocystis carinii) 
11. CMV*** 
12. Candida 
 
(N.B. * indicates atypical bacteria ** indicates gram-negative bacteria *** 
indicates viruses) 
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Risk factors for CAP 
Some risk factors for CAP are shown below (Zar et al., 2005; Chisti et al., 2009) 
 
Host factors 
  Infancy (Age <1 year)       
  Prematurity 
  Low birth weight  (including low weight for age)     
  Malnutrition       
  Immunosuppression 
 
Social/environmental 
 Overcrowding  
 Air pollution 
 Inadequate housing 
 Low socioeconomic status 
 Passive exposure to tobacco smoke 
 Indoor fuel exposure 
 Winter season  
 Lack of breast feeding 
 Failure to complete immunization 
 Attendance at day-care centres 
 Presence of coughing sibling (s) at home 
 
Pneumonia in SAM 
The WHO defines malnutrition as “the cellular imbalance between the supply of nutrients 
and energy and the energy and the body’s demand for them to ensure growth, maintenance, 
and specific functions (de Onis et al., 1993). Among the four principal causes of deaths in 
young children worldwide, undernutrition has been ascribed to be the cause of death in 
60.7% children with diarrhoeal diseases, 52.3% of those with pneumonia (Caulfield et al., 
2004). More than half of all the childhood deaths are associated with malnutrition (Rice et 
al., 2000). Pneumonia is common in malnourished children and frequently associated with 
fatal outcome (Bryce et al., 2005; Rice et al., 2000; Loeb & High, 2005; Nannan et al., 2007). Of 
children with malnutrition requiring hospital admission, up to two-thirds are diagnosed 
with pneumonia (Shimeles & Lulseged, 1994; Ahmed et al., 1999). A most recent systematic 
review revealed those children with pneumonia and moderate or severe malnutrition are at 
higher risk of death (Chisti et al., 2009). For SAM, the relative risks ranged from 2.9-121.2 
with odds ratios ranged from 2.5-15.1. For moderate malnutrition, the relative risks ranged 
from 1.2-36.5 (Chisti et al., 2009). The clinical classification of pneumonia based on the 
diagnostic criteria according to the WHO guidelines should be carefully evaluated in 
children with SAM. A Gambian study evaluated that the respiratory rate cut-off required in 
malnourished children should be taken approximately 5 breaths per minute less than that in 
well nourished children and this finding may be related to the lower body temperatures 
found in severely malnourished children with pneumonia (Falade et al., 1995). Similarly, 
intercostal indrawing was more common and lower chest wall indrawing was less common 
in severely malnourished children (Falade et al., 1995; Chisti et al., 2010). In addition, lower 
chest wall indrawing is not sufficiently sensitive as predictors of pneumonia in SAM and no 
visible clinical signs are consistently reliable for the diagnosis of pneumonia in SAM. 
Malnourished children may not have the strength to manifest some of these physical signs 
in the same manner as well nourished children (Falade et al., 1995; Chisti et al., 2010). 
Moreover, data from a recent systematic review suggest that a reliance on simple clinical 
signs will underestimate the burden of the disease and potentially delay the diagnosis of 
pneumonia in severely malnourished children (Chisti et al., 2009). Therefore, WHO 
recommends that children with SAM who present with cough, fast or difficult breathing 
irrespective of having clinical signs of pneumonia or not, should be treated with appropriate 
antibiotics to save the lives of these high-risk group of children (Falade et al., 1995). 
 
Occult pneumonia is another entity characterized by the absence of the clinical signs and 
may be diagnosed by performing a chest radiograph; it may occur in SAM with dehydrating 
diarrhoea (Hall & Simon, 1987; Murphy et al., 2007; Bachur et al., 1999). The typical clinical 
signs of pneumonia may be absent in SAM due to sub-optimal inflammatory responses, 
reduced power of the respiratory muscles, and depletion of potassium and magnesium 
(Suskind et al., 1990). SAM also contributes to immune deficiency and reduced host defense. 
 
Pneumonia with dehydrating diarrhoea 
The clinical classification of pneumonia based on the diagnostic criteria according to WHO 
should be carefully evaluated in children presenting with dehydrating diarrhoea caused by 
Vibrio cholerae, ETEC, as well as rotavirus. If a child presents with severe or some degree of 
dehydration, then s/he would likely to have acidosis, which is responsible for the 
development of tachypnoea and it would be very difficult to distinguish clinically whether the 
increased respiratory rate is due to pneumonia, or due to acidosis, or both. In this situation, it 
is generally recommended to fully rehydrate the child first with IV/oral fluid (according to the 
type of dehydration present) within 4-6 hours and then count the respiratory rate for detecting 
pneumonia according to the standard WHO guideline. It is also recommended to perform a 
chest radiograph after full hydration of the patient for confirming the diagnosis of pneumonia. 
 
Diagnosis of CAP 
The diagnosis of CAP should be considered in any child who has an acute onset of respiratory 
symptoms, particularly cough, fast breathing, or difficulty in breathing. Diagnosis includes 
clinical evaluation, radiographic evaluation and etiological investigations to: (i) establish whether 
pneumonia is present; (ii) assess the severity of pneumonia; (iii) determine the clinical type of 
pneumonia; and (iii) determine the causative organism. In general, diagnostic investigations to 
determine the cause of pneumonia are indicated only in children requiring hospitalization  
(Zar et al., 2005). Bacterial pneumonia cannot be reliably distinguished from viral pneumonia on 
the basis of any single parameter: clinical, laboratory, or chest radiographic findings. 
 
 Clinical evaluation 
 Radiographic evaluation 
 Aetiological investigations 
 Pulse oximetry  
The best objective measurement of hypoxaemia is by pulse oximetry which avoids the need 
for arterial blood gases. Oxygen saturation (Sao2) measurements provide a non-invasive 
estimate of the arterial oxygenation (BTS, 2002). The human eye is poor in recognizing 
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Risk factors for CAP 
Some risk factors for CAP are shown below (Zar et al., 2005; Chisti et al., 2009) 
 
Host factors 
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  Low birth weight  (including low weight for age)     
  Malnutrition       
  Immunosuppression 
 
Social/environmental 
 Overcrowding  
 Air pollution 
 Inadequate housing 
 Low socioeconomic status 
 Passive exposure to tobacco smoke 
 Indoor fuel exposure 
 Winter season  
 Lack of breast feeding 
 Failure to complete immunization 
 Attendance at day-care centres 
 Presence of coughing sibling (s) at home 
 
Pneumonia in SAM 
The WHO defines malnutrition as “the cellular imbalance between the supply of nutrients 
and energy and the energy and the body’s demand for them to ensure growth, maintenance, 
and specific functions (de Onis et al., 1993). Among the four principal causes of deaths in 
young children worldwide, undernutrition has been ascribed to be the cause of death in 
60.7% children with diarrhoeal diseases, 52.3% of those with pneumonia (Caulfield et al., 
2004). More than half of all the childhood deaths are associated with malnutrition (Rice et 
al., 2000). Pneumonia is common in malnourished children and frequently associated with 
fatal outcome (Bryce et al., 2005; Rice et al., 2000; Loeb & High, 2005; Nannan et al., 2007). Of 
children with malnutrition requiring hospital admission, up to two-thirds are diagnosed 
with pneumonia (Shimeles & Lulseged, 1994; Ahmed et al., 1999). A most recent systematic 
review revealed those children with pneumonia and moderate or severe malnutrition are at 
higher risk of death (Chisti et al., 2009). For SAM, the relative risks ranged from 2.9-121.2 
with odds ratios ranged from 2.5-15.1. For moderate malnutrition, the relative risks ranged 
from 1.2-36.5 (Chisti et al., 2009). The clinical classification of pneumonia based on the 
diagnostic criteria according to the WHO guidelines should be carefully evaluated in 
children with SAM. A Gambian study evaluated that the respiratory rate cut-off required in 
malnourished children should be taken approximately 5 breaths per minute less than that in 
well nourished children and this finding may be related to the lower body temperatures 
found in severely malnourished children with pneumonia (Falade et al., 1995). Similarly, 
intercostal indrawing was more common and lower chest wall indrawing was less common 
in severely malnourished children (Falade et al., 1995; Chisti et al., 2010). In addition, lower 
chest wall indrawing is not sufficiently sensitive as predictors of pneumonia in SAM and no 
visible clinical signs are consistently reliable for the diagnosis of pneumonia in SAM. 
Malnourished children may not have the strength to manifest some of these physical signs 
in the same manner as well nourished children (Falade et al., 1995; Chisti et al., 2010). 
Moreover, data from a recent systematic review suggest that a reliance on simple clinical 
signs will underestimate the burden of the disease and potentially delay the diagnosis of 
pneumonia in severely malnourished children (Chisti et al., 2009). Therefore, WHO 
recommends that children with SAM who present with cough, fast or difficult breathing 
irrespective of having clinical signs of pneumonia or not, should be treated with appropriate 
antibiotics to save the lives of these high-risk group of children (Falade et al., 1995). 
 
Occult pneumonia is another entity characterized by the absence of the clinical signs and 
may be diagnosed by performing a chest radiograph; it may occur in SAM with dehydrating 
diarrhoea (Hall & Simon, 1987; Murphy et al., 2007; Bachur et al., 1999). The typical clinical 
signs of pneumonia may be absent in SAM due to sub-optimal inflammatory responses, 
reduced power of the respiratory muscles, and depletion of potassium and magnesium 
(Suskind et al., 1990). SAM also contributes to immune deficiency and reduced host defense. 
 
Pneumonia with dehydrating diarrhoea 
The clinical classification of pneumonia based on the diagnostic criteria according to WHO 
should be carefully evaluated in children presenting with dehydrating diarrhoea caused by 
Vibrio cholerae, ETEC, as well as rotavirus. If a child presents with severe or some degree of 
dehydration, then s/he would likely to have acidosis, which is responsible for the 
development of tachypnoea and it would be very difficult to distinguish clinically whether the 
increased respiratory rate is due to pneumonia, or due to acidosis, or both. In this situation, it 
is generally recommended to fully rehydrate the child first with IV/oral fluid (according to the 
type of dehydration present) within 4-6 hours and then count the respiratory rate for detecting 
pneumonia according to the standard WHO guideline. It is also recommended to perform a 
chest radiograph after full hydration of the patient for confirming the diagnosis of pneumonia. 
 
Diagnosis of CAP 
The diagnosis of CAP should be considered in any child who has an acute onset of respiratory 
symptoms, particularly cough, fast breathing, or difficulty in breathing. Diagnosis includes 
clinical evaluation, radiographic evaluation and etiological investigations to: (i) establish whether 
pneumonia is present; (ii) assess the severity of pneumonia; (iii) determine the clinical type of 
pneumonia; and (iii) determine the causative organism. In general, diagnostic investigations to 
determine the cause of pneumonia are indicated only in children requiring hospitalization  
(Zar et al., 2005). Bacterial pneumonia cannot be reliably distinguished from viral pneumonia on 
the basis of any single parameter: clinical, laboratory, or chest radiographic findings. 
 
 Clinical evaluation 
 Radiographic evaluation 
 Aetiological investigations 
 Pulse oximetry  
The best objective measurement of hypoxaemia is by pulse oximetry which avoids the need 
for arterial blood gases. Oxygen saturation (Sao2) measurements provide a non-invasive 
estimate of the arterial oxygenation (BTS, 2002). The human eye is poor in recognizing 
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hypoxaemia. Even under ideal conditions, skilled observers cannot consistently detect 
hypoxaemia until the oxygen (O2) saturation is below 80% (Comroe & Bothello, 1947). Pulse 
oximetry is probably one of the most important advances in monitoring the respiratory 
problems and these instruments have a reasonable degree of accuracy (Jurban, 1999). The 
pulse oximeter is easy to use and requires no calibration. However, it requires a pulsatile 
signal from the patient. When using paediatric wrap around probes, the emitting and 
receiving diodes need to be carefully opposed. It is also highly subject to motion artifacts. To 
obtain a reliable reading (i) the child should be resting, still and quiet, not crying or irritable 
(Zar et al., 2005; BTS, 2002); (i) a good pulse signal (plethysmograph) should be obtained; 
and (iii) once a signal is obtained, the saturation reading should be watched over at least 30 
seconds and a value recorded once an adequate stable trace is obtained (Zar et al., 2005; BTS, 
2002). Pulse oximetry as a potentially useful diagnostic tool for the detection of hypoxaemia 
as an indicator of severe pneumonia; have not been sufficiently evaluated for the diagnosis 
of children with SAM (WHO, 2005). Widespread use of pulse oximetry is now 
recommended for monitoring children with severe pneumonia in the developing countries. 
Perhaps the major challenge facing pulse oximetry is whether this technology can be 
incorporated effectively into the diagnostic and management algorithms that can improve 
the efficiency of clinical management of CAP in the developing countries (Jurban, 1999). 
 
Significance of hypoxaemia with CAP and its management 
Assessment of oxygenation is important in the evaluation of a child with pneumonia and 
pulse oximetry should be performed in every child admitted to a hospital with CAP (Zar et 
al., 2005; BTS, 2002). Hypoxaemia is defined as the arterial oxygen saturation of less than 
90% in room air at sea level as recorded by the pulse oximetry, which is the most serious 
manifestation of childhood pneumonia (Weber et al., 1997). In white patients, an SPO2 target 
of 92% resulted in a satisfactory level of oxygenation, whereas a higher SPO2 target of 95% 
was required in black patients (Jurban, 1999; Jurban & Tobin, 1990). Alternatively, no 
hypoxaemia is defined as the arterial oxygen saturation of ≥90% in room air as recorded by 
the pulse oximetry. The median prevalence of hypoxaemia in WHO-defined pneumonia 
requiring hospitalization (severe and very severe pneumonia) was 13% but the prevalence 
varied widely (Subhi, 2009). This corresponds to at least 1.5 to 2.7 million annual cases of 
pneumonia with hypoxaemia presenting to the health-care facilities (Subhi, 2009). WHO 
recommends for children older than 2 months, the use of oxygen in severe/very severe 
pneumonia, as ascertained by the presence of a number of clinical indicators of hypoxaemia, 
including cyanosis, inability to drink, severe lower chest wall indrawing, respiratory rate 
greater than 70 breaths per minute, grunting respiration, or head nodding (WHO, 2005). 
Head nodding is a movement of the head synchronous with each breath, which is caused by 
increased use of auxiliary muscles of respiration and therefore indicates severe respiratory 
distress and an important clinical sign predicting hypoxaemia (Weber et al., 1997). Only one 
Gambian study showed that hypoxaemia could be predicted in only half of the children by 
the presence of a combination of three clinical signs, such as extreme respiratory distress, 
cyanosis, and severely compromised general status (Weber et al., 1997). Agitation may be an 
indication that the child is hypoxaemic (BTS, 2002). Hypoxaemia is also a good indicator for 
detecting the severity of pneumonia (Wang et al., 1995; Hall et al., 1979; Shann et al., 1989). It 
is a common complication of childhood infections, particularly ALRI, and case fatality rate 
of pneumonia is inversely related to the arterial haemoglobin oxygen saturation (SaO2) 
(Onyango et al., 1993). In pneumonia - a disease that disproportionately impacts the 
developing countries, hypoxaemia is an important risk factor for death (Onyango et al., 
1993; Duke et al. 2000), as hypoxaemic children are five times more likely to die than non-
hypoxaemic children. In patients admitted with pneumonia to a general medical service, it 
was found that O2 saturation <90% of at least 5 minutes duration occurred in 26% of the 
patients (Bowton et al., 1994). On follow-up over the next 4-7 months, those patients 
experiencing hypoxaemia during the first 24 hour of hospitalization had more than a 
threefold higher mortality than patients who did not desaturate (Bowton et al., 1994).  
In the critical care setting especially for evaluating the progress of children suffering from 
severe pneumonia, pulse oximetry is also used as one of the most commonly employed 
monitoring modalities in the critical care setting especially for evaluating the progress of 
children suffering from severe pneumonia (Jurban, 1999). Moreover, hypoxaemia is also an 
important risk factor for failure to the day-care management as well as the need for future 
follow-up admissions (Ashraf et al., 2010). Therefore, measurement of oxygen saturation 
should be routinely done in all children with severe pneumonia with pulse oximetry, and 
those with hypoxaemia requiring prolonged oxygen therapy for more than six hours should 
be referred to a hospital for long-term oxygen therapy (Ashraf et al., 2010). Results of that 
study were consistent with earlier reports that hypoxaemia in pneumonic children are 
predictors of severe disease and is a risk factor for death (Onyango et al., 1993; Duke et al., 
2000). Hypoxaemia has been overlooked in world-wide strategies for pneumonia control 
and reducing child mortality (Subhi, 2009). It is also often overlooked in the developing 
countries, mainly due to the low accuracy of clinical predictors and the limited availability 
of pulse oximetry, despite of its more accurate detection of hypoxaemia and oxygen therapy 
for treatment (Subhi, 2009). Many more people do not have access to the health care 
facilities. Oxygen therapy in developing countries continues to be a low priority on the child 
health agenda (Subhi, 2009). Oxygen was never mentioned in the recent publication by the 
WHO and UNICEF efforts to control pneumonia (Wardlaw et al., 2006). The accurate 
detection of hypoxaemia is important as delivery of oxygen to the hypoxaemic children may 
improve the outcome. Especially in a setting where oxygen has to be bought in cylinders, a 
pulse oximeter might be a cost effective purchase, as it allows identification of children who 
are in need of oxygen, and the amount of oxygen given can be titrated to the actual need of 
the patient, thus avoiding unnecessary wastage of valuable oxygen (Weber et al., 1997). 
There is now evidence that ensuring ample supplies of oxygen and promoting a routine and 
systematic approach of screening for hypoxaemia by using pulse oximetry is associated with 
improved quality of care and reduced mortality, and that the technology required to do so is 
affordable and sustainable in district level hospitals and day-care centres in the developing 
countries (Duke et al., 2000, Dobson et al., 1996; Duke et al., 2008; Dobson, 1991; Steinhoff & 
Black, 2007; Matai et al., 2008). Pulse oximetry would enable accurate identification of 
hypoxaemia and might increase the safety and cost effectiveness of this recommendation 
and this diagnostic tool should be included. This was demonstrated by our recent study 
reporting successful day-care case management of severe pneumonia using pulse oximetry 
as an important part of the treatment algorithm (Ashraf et al., 2008). Hypoxaemia is a very 
common and treatable complication of childhood pneumonia in developing countries and it 
is a recognized predictor of severe disease and a risk factor for death and correlates with 
disease severity. For home management to be safe and ethical, it is essential that only 
children without hypoxaemia are managed outside health-care facilities (Subhi et al., 2009). 
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hypoxaemia. Even under ideal conditions, skilled observers cannot consistently detect 
hypoxaemia until the oxygen (O2) saturation is below 80% (Comroe & Bothello, 1947). Pulse 
oximetry is probably one of the most important advances in monitoring the respiratory 
problems and these instruments have a reasonable degree of accuracy (Jurban, 1999). The 
pulse oximeter is easy to use and requires no calibration. However, it requires a pulsatile 
signal from the patient. When using paediatric wrap around probes, the emitting and 
receiving diodes need to be carefully opposed. It is also highly subject to motion artifacts. To 
obtain a reliable reading (i) the child should be resting, still and quiet, not crying or irritable 
(Zar et al., 2005; BTS, 2002); (i) a good pulse signal (plethysmograph) should be obtained; 
and (iii) once a signal is obtained, the saturation reading should be watched over at least 30 
seconds and a value recorded once an adequate stable trace is obtained (Zar et al., 2005; BTS, 
2002). Pulse oximetry as a potentially useful diagnostic tool for the detection of hypoxaemia 
as an indicator of severe pneumonia; have not been sufficiently evaluated for the diagnosis 
of children with SAM (WHO, 2005). Widespread use of pulse oximetry is now 
recommended for monitoring children with severe pneumonia in the developing countries. 
Perhaps the major challenge facing pulse oximetry is whether this technology can be 
incorporated effectively into the diagnostic and management algorithms that can improve 
the efficiency of clinical management of CAP in the developing countries (Jurban, 1999). 
 
Significance of hypoxaemia with CAP and its management 
Assessment of oxygenation is important in the evaluation of a child with pneumonia and 
pulse oximetry should be performed in every child admitted to a hospital with CAP (Zar et 
al., 2005; BTS, 2002). Hypoxaemia is defined as the arterial oxygen saturation of less than 
90% in room air at sea level as recorded by the pulse oximetry, which is the most serious 
manifestation of childhood pneumonia (Weber et al., 1997). In white patients, an SPO2 target 
of 92% resulted in a satisfactory level of oxygenation, whereas a higher SPO2 target of 95% 
was required in black patients (Jurban, 1999; Jurban & Tobin, 1990). Alternatively, no 
hypoxaemia is defined as the arterial oxygen saturation of ≥90% in room air as recorded by 
the pulse oximetry. The median prevalence of hypoxaemia in WHO-defined pneumonia 
requiring hospitalization (severe and very severe pneumonia) was 13% but the prevalence 
varied widely (Subhi, 2009). This corresponds to at least 1.5 to 2.7 million annual cases of 
pneumonia with hypoxaemia presenting to the health-care facilities (Subhi, 2009). WHO 
recommends for children older than 2 months, the use of oxygen in severe/very severe 
pneumonia, as ascertained by the presence of a number of clinical indicators of hypoxaemia, 
including cyanosis, inability to drink, severe lower chest wall indrawing, respiratory rate 
greater than 70 breaths per minute, grunting respiration, or head nodding (WHO, 2005). 
Head nodding is a movement of the head synchronous with each breath, which is caused by 
increased use of auxiliary muscles of respiration and therefore indicates severe respiratory 
distress and an important clinical sign predicting hypoxaemia (Weber et al., 1997). Only one 
Gambian study showed that hypoxaemia could be predicted in only half of the children by 
the presence of a combination of three clinical signs, such as extreme respiratory distress, 
cyanosis, and severely compromised general status (Weber et al., 1997). Agitation may be an 
indication that the child is hypoxaemic (BTS, 2002). Hypoxaemia is also a good indicator for 
detecting the severity of pneumonia (Wang et al., 1995; Hall et al., 1979; Shann et al., 1989). It 
is a common complication of childhood infections, particularly ALRI, and case fatality rate 
of pneumonia is inversely related to the arterial haemoglobin oxygen saturation (SaO2) 
(Onyango et al., 1993). In pneumonia - a disease that disproportionately impacts the 
developing countries, hypoxaemia is an important risk factor for death (Onyango et al., 
1993; Duke et al. 2000), as hypoxaemic children are five times more likely to die than non-
hypoxaemic children. In patients admitted with pneumonia to a general medical service, it 
was found that O2 saturation <90% of at least 5 minutes duration occurred in 26% of the 
patients (Bowton et al., 1994). On follow-up over the next 4-7 months, those patients 
experiencing hypoxaemia during the first 24 hour of hospitalization had more than a 
threefold higher mortality than patients who did not desaturate (Bowton et al., 1994).  
In the critical care setting especially for evaluating the progress of children suffering from 
severe pneumonia, pulse oximetry is also used as one of the most commonly employed 
monitoring modalities in the critical care setting especially for evaluating the progress of 
children suffering from severe pneumonia (Jurban, 1999). Moreover, hypoxaemia is also an 
important risk factor for failure to the day-care management as well as the need for future 
follow-up admissions (Ashraf et al., 2010). Therefore, measurement of oxygen saturation 
should be routinely done in all children with severe pneumonia with pulse oximetry, and 
those with hypoxaemia requiring prolonged oxygen therapy for more than six hours should 
be referred to a hospital for long-term oxygen therapy (Ashraf et al., 2010). Results of that 
study were consistent with earlier reports that hypoxaemia in pneumonic children are 
predictors of severe disease and is a risk factor for death (Onyango et al., 1993; Duke et al., 
2000). Hypoxaemia has been overlooked in world-wide strategies for pneumonia control 
and reducing child mortality (Subhi, 2009). It is also often overlooked in the developing 
countries, mainly due to the low accuracy of clinical predictors and the limited availability 
of pulse oximetry, despite of its more accurate detection of hypoxaemia and oxygen therapy 
for treatment (Subhi, 2009). Many more people do not have access to the health care 
facilities. Oxygen therapy in developing countries continues to be a low priority on the child 
health agenda (Subhi, 2009). Oxygen was never mentioned in the recent publication by the 
WHO and UNICEF efforts to control pneumonia (Wardlaw et al., 2006). The accurate 
detection of hypoxaemia is important as delivery of oxygen to the hypoxaemic children may 
improve the outcome. Especially in a setting where oxygen has to be bought in cylinders, a 
pulse oximeter might be a cost effective purchase, as it allows identification of children who 
are in need of oxygen, and the amount of oxygen given can be titrated to the actual need of 
the patient, thus avoiding unnecessary wastage of valuable oxygen (Weber et al., 1997). 
There is now evidence that ensuring ample supplies of oxygen and promoting a routine and 
systematic approach of screening for hypoxaemia by using pulse oximetry is associated with 
improved quality of care and reduced mortality, and that the technology required to do so is 
affordable and sustainable in district level hospitals and day-care centres in the developing 
countries (Duke et al., 2000, Dobson et al., 1996; Duke et al., 2008; Dobson, 1991; Steinhoff & 
Black, 2007; Matai et al., 2008). Pulse oximetry would enable accurate identification of 
hypoxaemia and might increase the safety and cost effectiveness of this recommendation 
and this diagnostic tool should be included. This was demonstrated by our recent study 
reporting successful day-care case management of severe pneumonia using pulse oximetry 
as an important part of the treatment algorithm (Ashraf et al., 2008). Hypoxaemia is a very 
common and treatable complication of childhood pneumonia in developing countries and it 
is a recognized predictor of severe disease and a risk factor for death and correlates with 
disease severity. For home management to be safe and ethical, it is essential that only 
children without hypoxaemia are managed outside health-care facilities (Subhi et al., 2009). 
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Children with hypoxaemic pneumonia requiring prolonged oxygen therapy for more than 
six hours, need to be identified (which is often difficult using only clinical signs), admitted, 
and given supplemental oxygen for prolonged duration, and close monitoring (Ashraf et al. 
2010). The measurement of SpO2 as a regularly measured vital sign by using pulse oximetry 
should be incorporated as an important part of the treatment algorithm for improving the 
diagnosis of hypoxaemia, and categorizing the severity of pneumonia (Onyango et al., 1993; 
Steinhoff & Black, 2007; Lozano et al., 1994; Weber & Mulholland, 1998). For treating 
children with pneumonia, there is an urgent need to increase the widespread availability as 
well as use of pulse oximetry for monitoring patients with severe pneumonia and effective 
oxygen delivery systems in the developing countries.  
 
Classification of hypoxaemia 
There are two ways of classifying hypoxaemia in children: (i) WHO classification and (ii) 
British Thoracic Society (BTS) classification as defined below:   
 
(i) WHO classification of hypoxaemia 
 
Experts from WHO often classifies hypoxaemia as mild, moderate and severe as defined below: 
 
 Mild hypoxaemia: when the arterial oxygen saturation lies between 85 to 90%, the 
patient is known to have mild hypoxaemia. 
 Moderate hypoxaemia: when the arterial oxygen saturation lies between 80 to 85%, 
the patient is known to have moderate hypoxaemia.  
 Severe hypoxaemia: when the arterial oxygen saturation is less than 80%, the 
patient is known to have severe hypoxaemia. 
 
(ii) BTS classification of hypoxaemia 
 
Similarly, experts from paediatric respiratory medicine in developed countries including 
BTS often categorized hypoxaemia as mild, moderate and severe as defined below: 
 
 Mild hypoxaemia: when the arterial oxygen saturation lies between 88 to 92%, the 
patient is known to have mild hypoxaemia. 
 Moderate hypoxaemia: when the arterial oxygen saturation lies between 85 to 88%, 
the patient is known to have moderate hypoxaemia.  
 Severe hypoxaemia: when the arterial oxygen saturation is less than 85%, the 
patient is known to have severe hypoxaemia.  
 
Indications for oxygen therapy 
1. Hypoxaemia (oxygen saturation <90% in room air at sea level) 
2. Central cyanosis 
3. Severe lower chest-wall in-drawing 
4. Grunting respiration 
5. Restlessness (due to hypoxaemia) 
6. Inability to drink or feed 
7. Respiratory rate >70 breaths/min 
8. Head Nodding 
Management of hypoxaemia 
 Oxygen should be available at any health care facility where sick children are seen 
regularly. Oxygen therapy reduces mortality associated with severe pneumonia. It 
should be given to children who are restless, who had tachypnoea with severe 
lower chest wall in-drawing, head nodding, cyanosis, or not tolerating oral feeds. 
The SpO2 should be maintained above 92%. 
 If oxygen is required infrequently then cylinders are the most practical source of 
oxygen. Cylinders also allow oxygen therapy to be used while the patient is 
transferred to a facility with more resources. 
 If oxygen is used more frequently, then oxygen concentrators are the preferred 
source of oxygen. 
 In hospitals with oxygen supplies, wall oxygen units should be available. 
 Low flow meters must be available to give appropriate oxygen flow to children. In 
most hospitals these will be variable orifice units, but fixed orifice units may be 
more practical in some units. 
 
Key messages about hypoxaemia in relation to CAP (WHO, 2009) 
 Hypoxaemia is a common complication in ALRI in children, and is a strong 
risk factor for death. 
 At least 13% of children presenting to hospitals with severe or very severe 
pneumonia have hypoxaemia, and the rates are much higher in some 
hospitals; some exceeding 50%. 
 The prevalence of hypoxaemia is higher in referral hospitals than in primary 
care settings. Hypoxaemia is more common at higher altitude, in younger 
ages and in certain geographical regions. 
 SpO2 <90% is the most clinically useful definition of hypoxaemia and is 
considered by most clinicians as an appropriate indication for giving 
oxygen.  
 If pulse oximetry is available only at the time of admission, screen all 
patients if time allows, or those patients with any clinical signs of 
hypoxaemia, including all children with emergency or priority signs. 
 If oximetry is used at outpatient triage, screen all children with any 
emergency or priority signs. 
 Any child with an SpO2 <90% should receive oxygen. 
 Use oximetry, at least daily, to check any patients who are already on 
oxygen, and screen any patient who develops any emergency signs or 
shows other clinical signs of deterioration. 
 Explain the meaning of oximetry to parents. This will help them understand 
the importance of oxygen and other treatments and will involve them in 
their child’s care. 
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Children with hypoxaemic pneumonia requiring prolonged oxygen therapy for more than 
six hours, need to be identified (which is often difficult using only clinical signs), admitted, 
and given supplemental oxygen for prolonged duration, and close monitoring (Ashraf et al. 
2010). The measurement of SpO2 as a regularly measured vital sign by using pulse oximetry 
should be incorporated as an important part of the treatment algorithm for improving the 
diagnosis of hypoxaemia, and categorizing the severity of pneumonia (Onyango et al., 1993; 
Steinhoff & Black, 2007; Lozano et al., 1994; Weber & Mulholland, 1998). For treating 
children with pneumonia, there is an urgent need to increase the widespread availability as 
well as use of pulse oximetry for monitoring patients with severe pneumonia and effective 
oxygen delivery systems in the developing countries.  
 
Classification of hypoxaemia 
There are two ways of classifying hypoxaemia in children: (i) WHO classification and (ii) 
British Thoracic Society (BTS) classification as defined below:   
 
(i) WHO classification of hypoxaemia 
 
Experts from WHO often classifies hypoxaemia as mild, moderate and severe as defined below: 
 
 Mild hypoxaemia: when the arterial oxygen saturation lies between 85 to 90%, the 
patient is known to have mild hypoxaemia. 
 Moderate hypoxaemia: when the arterial oxygen saturation lies between 80 to 85%, 
the patient is known to have moderate hypoxaemia.  
 Severe hypoxaemia: when the arterial oxygen saturation is less than 80%, the 
patient is known to have severe hypoxaemia. 
 
(ii) BTS classification of hypoxaemia 
 
Similarly, experts from paediatric respiratory medicine in developed countries including 
BTS often categorized hypoxaemia as mild, moderate and severe as defined below: 
 
 Mild hypoxaemia: when the arterial oxygen saturation lies between 88 to 92%, the 
patient is known to have mild hypoxaemia. 
 Moderate hypoxaemia: when the arterial oxygen saturation lies between 85 to 88%, 
the patient is known to have moderate hypoxaemia.  
 Severe hypoxaemia: when the arterial oxygen saturation is less than 85%, the 
patient is known to have severe hypoxaemia.  
 
Indications for oxygen therapy 
1. Hypoxaemia (oxygen saturation <90% in room air at sea level) 
2. Central cyanosis 
3. Severe lower chest-wall in-drawing 
4. Grunting respiration 
5. Restlessness (due to hypoxaemia) 
6. Inability to drink or feed 
7. Respiratory rate >70 breaths/min 
8. Head Nodding 
Management of hypoxaemia 
 Oxygen should be available at any health care facility where sick children are seen 
regularly. Oxygen therapy reduces mortality associated with severe pneumonia. It 
should be given to children who are restless, who had tachypnoea with severe 
lower chest wall in-drawing, head nodding, cyanosis, or not tolerating oral feeds. 
The SpO2 should be maintained above 92%. 
 If oxygen is required infrequently then cylinders are the most practical source of 
oxygen. Cylinders also allow oxygen therapy to be used while the patient is 
transferred to a facility with more resources. 
 If oxygen is used more frequently, then oxygen concentrators are the preferred 
source of oxygen. 
 In hospitals with oxygen supplies, wall oxygen units should be available. 
 Low flow meters must be available to give appropriate oxygen flow to children. In 
most hospitals these will be variable orifice units, but fixed orifice units may be 
more practical in some units. 
 
Key messages about hypoxaemia in relation to CAP (WHO, 2009) 
 Hypoxaemia is a common complication in ALRI in children, and is a strong 
risk factor for death. 
 At least 13% of children presenting to hospitals with severe or very severe 
pneumonia have hypoxaemia, and the rates are much higher in some 
hospitals; some exceeding 50%. 
 The prevalence of hypoxaemia is higher in referral hospitals than in primary 
care settings. Hypoxaemia is more common at higher altitude, in younger 
ages and in certain geographical regions. 
 SpO2 <90% is the most clinically useful definition of hypoxaemia and is 
considered by most clinicians as an appropriate indication for giving 
oxygen.  
 If pulse oximetry is available only at the time of admission, screen all 
patients if time allows, or those patients with any clinical signs of 
hypoxaemia, including all children with emergency or priority signs. 
 If oximetry is used at outpatient triage, screen all children with any 
emergency or priority signs. 
 Any child with an SpO2 <90% should receive oxygen. 
 Use oximetry, at least daily, to check any patients who are already on 
oxygen, and screen any patient who develops any emergency signs or 
shows other clinical signs of deterioration. 
 Explain the meaning of oximetry to parents. This will help them understand 
the importance of oxygen and other treatments and will involve them in 
their child’s care. 
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 Children should not be discharged until their SpO2 has been stable at 90% or 
more while breathing room air for at least 24 hours, until all emergency 
and priority signs have resolved, and until appropriate home treatment 
can be organized. 
 
Methods of oxygen administration 
 Nasal prongs: are recommended for most children. Nasal prongs give a 
maximum fractional concentration of inspired oxygen (F1O2) of 28-35% 
except in small infants when higher concentrations may be obtained. This 
method does not require humidification of oxygen and ensures that the 
child receives oxygen during feeding. Oxygen flow rates of 0.5-1 l/minute 
are required in children less than 2 months old and 2-3 l/minute in infants 
and children aged 2 months to 5 years. 
 Nasal catheters: are usually well tolerated and humidification is not 
required, but they can be blocked by mucous. Oxygen via nasal catheters 
gives a maximum F1O2 of 35-40%. 
 Nasopharyngeal catheters: have the advantage of requiring the lowest 
flow rate to achieve a given oxygen concentration in the airways. Infants 
under the age of 2 months can usually be treated with 0.5 minute and 
infants up to 1 year with 1 minute. However, humidification of oxygen is 
required and the catheter may be easily blocked. Further, potentially 
lethal complications including gastric distension, airway obstruction, 
apnoea, pneumo-orbitus and pneumocephalus may occur. Continuous 
skilled nursing is therefore necessary to prevent these complications. 
Consequently, oxygen administration via nasopharyngeal catheter is not 
recommended. 
 Headbox: oxygen is well tolerated by young infants. Headbox oxygen 
requires no humidification but requires a high flow and a mixing device 
to ensure the correct F1O2 is delivered. This is the least preferred method as 
there is wastage of oxygen and delivered F1O2 is unpredictable. 
 Facemask: oxygen is designed to deliver 28%-65% oxygen at a flow rate of 
6-10 minutes. 
 Polymask: In severely hypoxaemic infants who are not ventilated, oxygen 
should be administered using a polymask whereby F1O2 concentrations of 
60-80% may be achieved. The flow rate should be regulated to keep the 
bag of the mask inflated during inspiration and expiration. 
 Using the prone position for infants may improve hypoxaemia and the 
respiratory system compliance (Chaisupamongkollarp et al., 1999) and 
should be attempted if hypoxaemia is difficult to treat. 
 Oxygen should be discontinued when the child is improving and the 
transcutanous saturation is above 90% in room air, as recorded by the 
pulse oximetry. 
 
 
 
 
Radiological diagnosis 
Radiological changes may be vague or inconclusive or even absent despite the presence of 
clinical signs of pneumonia (Doherty, 1991; Hamid et al., 1996; Wafula et al., 1998: Chisti et 
al., 2009). Conversely, clinical signs of pneumonia can be absent in the presence of 
radiological signs of pneumonia (Murphy et al., 2007; Bachur et al., 1999; Chisti et al., 2009). 
There are two main clinical definitions of pneumonia based on the radiological findings: 
 
Bronchopneumonia is defined as a febrile illness with cough, respiratory distress with 
evidence of localized or more than one or generalized patchy infiltrates on the chest x-ray. 
 
Lobar pneumonia is defined as a febrile illness with cough, respiratory distress with an 
illness similar to that of bronchopneumonia, except that the physical findings (affected lobe 
reveals woody dull on percussion, rales, increased vocal resonance and/or bronchial breath 
sound on auscultation) and radiographic examination indicate lobar consolidation. 
 
Occult pneumonia: It was observed that approximately 25% of the febrile children defined 
as the rectal temperature becoming more than 380 Celsius (Ashraf et al., 2010), with a WBC 
count >20,000/mm3, but without any lower respiratory tract findings on examination, had 
radiographic evidence of pneumonia, known as occult pneumonia, commonly found in 
children with SAM and children with dehydrating diarrhoea (Murphy et al., 2007; Bachur et 
al., 1999; Chisti et al., 2009). 
 
Limitations of chest radiography 
 Less useful in discriminating the causative pathogens   
 Cannot accurately discriminate viral from bacterial pneumonias (Swingler, 2000).  
 Wide range of inter- and intra-observer variation in the interpretation (Swingler, 
2001; Bada et al., 2007; Pauls et al., 2007; Sarria et al., 2003), not only among the 
paediatricians, but also among the radiologists, even paediatric radiologists    
 Does not result in the improved outcome or change in the treatment of ambulatory 
settings (Swingler et al., 2000) 
 
Indications for CXR 
 To confirm the presence of pneumonia 
 To detect clinical pneumonia, unresponsive to the standard ambulatory 
management 
 To identify suspected cavitations or military mottling in PTB    
 To identify suspected foreign body aspiration 
 To identify hospitalized children for the detection of local complications of 
pneumonia, such as pleural effusion, pneumothorax, empyema thoracis, advanced 
stage of bronchiectasis, and lung abscess 
 High fever, leukocytosis with no obvious focus of infections (26% such cases may 
have radiographic pneumonia) (Bachur et al., 1999). 
 Children developing secondary heart failure 
 Children with congenital problems, such as Congenital Heart Disease (CHD), cystic 
fibrosis, Down’s Syndrome  
 Children with re-current attacks of pneumonia  
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 Children should not be discharged until their SpO2 has been stable at 90% or 
more while breathing room air for at least 24 hours, until all emergency 
and priority signs have resolved, and until appropriate home treatment 
can be organized. 
 
Methods of oxygen administration 
 Nasal prongs: are recommended for most children. Nasal prongs give a 
maximum fractional concentration of inspired oxygen (F1O2) of 28-35% 
except in small infants when higher concentrations may be obtained. This 
method does not require humidification of oxygen and ensures that the 
child receives oxygen during feeding. Oxygen flow rates of 0.5-1 l/minute 
are required in children less than 2 months old and 2-3 l/minute in infants 
and children aged 2 months to 5 years. 
 Nasal catheters: are usually well tolerated and humidification is not 
required, but they can be blocked by mucous. Oxygen via nasal catheters 
gives a maximum F1O2 of 35-40%. 
 Nasopharyngeal catheters: have the advantage of requiring the lowest 
flow rate to achieve a given oxygen concentration in the airways. Infants 
under the age of 2 months can usually be treated with 0.5 minute and 
infants up to 1 year with 1 minute. However, humidification of oxygen is 
required and the catheter may be easily blocked. Further, potentially 
lethal complications including gastric distension, airway obstruction, 
apnoea, pneumo-orbitus and pneumocephalus may occur. Continuous 
skilled nursing is therefore necessary to prevent these complications. 
Consequently, oxygen administration via nasopharyngeal catheter is not 
recommended. 
 Headbox: oxygen is well tolerated by young infants. Headbox oxygen 
requires no humidification but requires a high flow and a mixing device 
to ensure the correct F1O2 is delivered. This is the least preferred method as 
there is wastage of oxygen and delivered F1O2 is unpredictable. 
 Facemask: oxygen is designed to deliver 28%-65% oxygen at a flow rate of 
6-10 minutes. 
 Polymask: In severely hypoxaemic infants who are not ventilated, oxygen 
should be administered using a polymask whereby F1O2 concentrations of 
60-80% may be achieved. The flow rate should be regulated to keep the 
bag of the mask inflated during inspiration and expiration. 
 Using the prone position for infants may improve hypoxaemia and the 
respiratory system compliance (Chaisupamongkollarp et al., 1999) and 
should be attempted if hypoxaemia is difficult to treat. 
 Oxygen should be discontinued when the child is improving and the 
transcutanous saturation is above 90% in room air, as recorded by the 
pulse oximetry. 
 
 
 
 
Radiological diagnosis 
Radiological changes may be vague or inconclusive or even absent despite the presence of 
clinical signs of pneumonia (Doherty, 1991; Hamid et al., 1996; Wafula et al., 1998: Chisti et 
al., 2009). Conversely, clinical signs of pneumonia can be absent in the presence of 
radiological signs of pneumonia (Murphy et al., 2007; Bachur et al., 1999; Chisti et al., 2009). 
There are two main clinical definitions of pneumonia based on the radiological findings: 
 
Bronchopneumonia is defined as a febrile illness with cough, respiratory distress with 
evidence of localized or more than one or generalized patchy infiltrates on the chest x-ray. 
 
Lobar pneumonia is defined as a febrile illness with cough, respiratory distress with an 
illness similar to that of bronchopneumonia, except that the physical findings (affected lobe 
reveals woody dull on percussion, rales, increased vocal resonance and/or bronchial breath 
sound on auscultation) and radiographic examination indicate lobar consolidation. 
 
Occult pneumonia: It was observed that approximately 25% of the febrile children defined 
as the rectal temperature becoming more than 380 Celsius (Ashraf et al., 2010), with a WBC 
count >20,000/mm3, but without any lower respiratory tract findings on examination, had 
radiographic evidence of pneumonia, known as occult pneumonia, commonly found in 
children with SAM and children with dehydrating diarrhoea (Murphy et al., 2007; Bachur et 
al., 1999; Chisti et al., 2009). 
 
Limitations of chest radiography 
 Less useful in discriminating the causative pathogens   
 Cannot accurately discriminate viral from bacterial pneumonias (Swingler, 2000).  
 Wide range of inter- and intra-observer variation in the interpretation (Swingler, 
2001; Bada et al., 2007; Pauls et al., 2007; Sarria et al., 2003), not only among the 
paediatricians, but also among the radiologists, even paediatric radiologists    
 Does not result in the improved outcome or change in the treatment of ambulatory 
settings (Swingler et al., 2000) 
 
Indications for CXR 
 To confirm the presence of pneumonia 
 To detect clinical pneumonia, unresponsive to the standard ambulatory 
management 
 To identify suspected cavitations or military mottling in PTB    
 To identify suspected foreign body aspiration 
 To identify hospitalized children for the detection of local complications of 
pneumonia, such as pleural effusion, pneumothorax, empyema thoracis, advanced 
stage of bronchiectasis, and lung abscess 
 High fever, leukocytosis with no obvious focus of infections (26% such cases may 
have radiographic pneumonia) (Bachur et al., 1999). 
 Children developing secondary heart failure 
 Children with congenital problems, such as Congenital Heart Disease (CHD), cystic 
fibrosis, Down’s Syndrome  
 Children with re-current attacks of pneumonia  
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Indications for follow-up CXR 
 
 Children with lobar collapse 
 To document the resolution of a round pneumonia (as this may mimic the 
appearance of a Ghon focus) 
 Children with ongoing respiratory symptoms 
 Children with re-current attacks of pneumonia  
 
General tests of infection 
They may not be useful to differentiate bacterial from viral pneumonia (Nohynek et al., 
1995; Toikka et al., 2000; Korppi et al., 2003) 
 
● WBC count, neutrophil count (PMN leukocytosis suggests bacterial pneumonia (Marks & 
Klein, 1995; Klein, 1992) and lymphocytic leukopenia suggests viral pneumonia) (Austrian 
& Gold, 1964) 
● C-reactive protein (>40 mg suggests bacterial infection) 
● ESR  
● Procalcitonin 
● Copeptin 
● Blood culture: to identify the causative bacterial pathogen, that is possible in only less than 
30% (10-30%) of cases of CAP (Donowitz & Mandell, 1990), and to determine its sensitivity 
● Pleural fluid: if present, should be aspirated and investigated for specific infectious agents 
 
The C-reactive protein, ESR, procalcitonin, and copeptin are the non-specific markers for the 
diagnosis of pneumonia. 
 
Indications for hospital admission 
1. Hypoxaemia (oxygen saturation <90% in room air at sea level)     
2. Toxic appearance      
3. Respiratory rate >70/minute, or severe respiratory distress      
4. Infants < 2 months 
5. Impaired level of consciousness     
6. Inability to drink or eat     
7. Cyanosis    
8. Stridor in calm child 
9. Chronic lung disease 
10. Systemic manifestation 
11. Intermittent apnoea    
12. Grunting respiration    
13. Severe lower chest-wall indrawing   
14. SAM 
15. Family unable to provide adequate care/non-compliant parents     
16. Failure to respond ambulatory care/no response to previous oral antimicrobial therapy 
17. Clinical deterioration on treatment 
18. Immunocompromised host/immunodeficiency 
19. Recurrent pneumonia 
Indications for transfer and admission to Paediatric Intensive Care Unit (PICU) 
1. Needs ventilator support 
2. Failure to maintain a saturation of >90% with oxygen therapy 
3. Apnoea or slow irregular breathing 
4. Severely acidotic patient 
5. Exhaustion with rising respiratory rate and pulse rate 
6. Patient is in shock 
 
Differential diagnosis of a child with cough, or difficult breathing 
 
Diagnosis   Points in favour 
 
1. Pneumonia   Fast breathing 
    Lower chest wall indrawing 
    Crepitations on auscultation 
    Bronchial breathing 
    Nasal flaring 
    Grunting respiration 
    Head nodding 
 
2. Cardiac failure  Tachycardia 
Tachypnoea 
Enlarged tender liver  
Dependent oedema  
Raised jugular venous pressure 
    Central cyanosis 
    Heart murmur 
    Gallop rhythm 
 
3. Pneumothorax  Sudden onset 
Sudden onset of unexplained tachypnoea and 
respiratory distress (disproportionate to the severity of 
pneumonia) 
    Hyper-resonance chest on the affected side on percussion 
    Shift of mediastinum (trachea, apex beat to opposite side) 
Diminished or absent breath sound on auscultation on 
the affected side 
     
4. Pleural effusion, empyaema Stony dull on percussion (it is difficult to elicit in young  
    child) 
Diminished breath sound on the affected side of lesion 
    Shift of mediastinum (trachea, apex beat to opposite side) 
 
5. Pericardial effusion  Oedema feet  
    Raised jugular venous pressure 
    Apex beat not visible/not palpable 
    Increased area of cardiac dullness 
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Indications for follow-up CXR 
 
 Children with lobar collapse 
 To document the resolution of a round pneumonia (as this may mimic the 
appearance of a Ghon focus) 
 Children with ongoing respiratory symptoms 
 Children with re-current attacks of pneumonia  
 
General tests of infection 
They may not be useful to differentiate bacterial from viral pneumonia (Nohynek et al., 
1995; Toikka et al., 2000; Korppi et al., 2003) 
 
● WBC count, neutrophil count (PMN leukocytosis suggests bacterial pneumonia (Marks & 
Klein, 1995; Klein, 1992) and lymphocytic leukopenia suggests viral pneumonia) (Austrian 
& Gold, 1964) 
● C-reactive protein (>40 mg suggests bacterial infection) 
● ESR  
● Procalcitonin 
● Copeptin 
● Blood culture: to identify the causative bacterial pathogen, that is possible in only less than 
30% (10-30%) of cases of CAP (Donowitz & Mandell, 1990), and to determine its sensitivity 
● Pleural fluid: if present, should be aspirated and investigated for specific infectious agents 
 
The C-reactive protein, ESR, procalcitonin, and copeptin are the non-specific markers for the 
diagnosis of pneumonia. 
 
Indications for hospital admission 
1. Hypoxaemia (oxygen saturation <90% in room air at sea level)     
2. Toxic appearance      
3. Respiratory rate >70/minute, or severe respiratory distress      
4. Infants < 2 months 
5. Impaired level of consciousness     
6. Inability to drink or eat     
7. Cyanosis    
8. Stridor in calm child 
9. Chronic lung disease 
10. Systemic manifestation 
11. Intermittent apnoea    
12. Grunting respiration    
13. Severe lower chest-wall indrawing   
14. SAM 
15. Family unable to provide adequate care/non-compliant parents     
16. Failure to respond ambulatory care/no response to previous oral antimicrobial therapy 
17. Clinical deterioration on treatment 
18. Immunocompromised host/immunodeficiency 
19. Recurrent pneumonia 
Indications for transfer and admission to Paediatric Intensive Care Unit (PICU) 
1. Needs ventilator support 
2. Failure to maintain a saturation of >90% with oxygen therapy 
3. Apnoea or slow irregular breathing 
4. Severely acidotic patient 
5. Exhaustion with rising respiratory rate and pulse rate 
6. Patient is in shock 
 
Differential diagnosis of a child with cough, or difficult breathing 
 
Diagnosis   Points in favour 
 
1. Pneumonia   Fast breathing 
    Lower chest wall indrawing 
    Crepitations on auscultation 
    Bronchial breathing 
    Nasal flaring 
    Grunting respiration 
    Head nodding 
 
2. Cardiac failure  Tachycardia 
Tachypnoea 
Enlarged tender liver  
Dependent oedema  
Raised jugular venous pressure 
    Central cyanosis 
    Heart murmur 
    Gallop rhythm 
 
3. Pneumothorax  Sudden onset 
Sudden onset of unexplained tachypnoea and 
respiratory distress (disproportionate to the severity of 
pneumonia) 
    Hyper-resonance chest on the affected side on percussion 
    Shift of mediastinum (trachea, apex beat to opposite side) 
Diminished or absent breath sound on auscultation on 
the affected side 
     
4. Pleural effusion, empyaema Stony dull on percussion (it is difficult to elicit in young  
    child) 
Diminished breath sound on the affected side of lesion 
    Shift of mediastinum (trachea, apex beat to opposite side) 
 
5. Pericardial effusion  Oedema feet  
    Raised jugular venous pressure 
    Apex beat not visible/not palpable 
    Increased area of cardiac dullness 
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Heart sound (muffled or absent) 
Pulsus paradoxus   
    Enlarged liver 
 
Pneumonia in older children often present in many ways 
The following two classic presentations have been described for pneumonia (Jadavi et al., 
1997) 
 
Typical presentation (predominantly respiratory signs) 
 Fever 
 Chills 
 Pleuritic chest pain 
 Productive cough 
 Fast breathing 
 Lower chest wall indrawing 
 Cyanosis 
 
Atypical presentations (single or in combinations) gradual onset over several days to weeks: 
 Nonproductive cough 
 Low-grade fever 
 Headache 
 Malaise 
 Meningism 
 Acute abdominal pain 
 Acute pain in chest or shoulder 
 Convulsion 
 
Antibiotic use in the treatment of CAP 
When treating CAP, the clinical, laboratory and radiographic findings should be considered, 
especially when the child is hospitalized. As it is difficult to distinguish bacterial from viral 
pneumonia and because of the frequency of mixed bacterial-viral infections (≈30-40%) (Zar 
et al., 2005), all children with CAP would require an antibiotic. The age of the child, 
nutritional status, immunologic status of the host, local epidemiology of respiratory 
pathogens, and sensitivity of these pathogens to particular antimicrobial agents and the 
emergence of antimicrobial resistance usually play a big role to determine the choice of 
antibiotic therapy. The severity of pneumonia and the drug costs also have a great impact on 
the selection of antimicrobial therapy, particularly in the developing countries. The 
management of a child with CAP involves a number of decisions regarding treatment with 
antibiotics (BTS, 2002). 
 
 Whether to treat with antibiotics? 
 Which antibiotic and by which route? 
 When to change to oral treatment? 
 Total duration of antibiotic therapy; 
 When to change antibiotic and why? 
 
Outpatient management 
In children with mild pneumonia (non-severe pneumonia), the breathing is fast, but there is 
no lower chest wall indrawing. Oral antibiotics at an appropriate dose for an adequate 
duration are effective for treatment. The mother is advised to return in two days for 
reassessment, or earlier if the child appears to deteriorate. 
 
Antimicrobial agent Recommended dosage Route Comment 
                                              Neonate (0-4 weeks) 
Ampicillin plus 
Gentamicin 
100 mg/kg/day 12 hourly 
6 mg/kg/day 12 hourly 
I/V 
I/V 
1st line of 
treatment 
Ceftazidime plus  
Flucloxacillin  
75-100 mg/kg/day 8 hrly 
100 mg/kg/day 6 hourly  
I/V 
I/V 
2nd line of 
treatment 
                                              Infants > 4-8 weeks 
Ampicillin plus 
Gentamicin 
100 mg/kg/day 6 hourly 
6 mg/kg/day 12 hourly 
I/V 
I/V 
1st line of 
treatment 
Ceftriaxone plus 
Gentamicin  
75-100 mg/kg/day od 
6 mg/kg/day 12 hourly 
I/V 
I/V 
2nd line of 
treatment 
                                              Infants >8 weeks to children of 5 years plus above 5 years 
Amoxicillin 100 mg/kg/day 8 hourly Oral 1st line of 
treatment 
Azithromycin 10 mg/kg/day once daily Oral 2nd line of 
treatment 
Ceftriaxone 75-100 mg/kg/day od I/V 3rd  line of 
treatment 
                                              Severe pneumonia with SAM 
Ampicillin plus 
Gentamicin 
100 mg/kg/day 6 hourly 
6 mg/kg/day 12 hourly 
I/V 
I/V 
1st line of 
treatment 
Ceftriaxone plus 
Gentamicin  
75-100 mg/kg/day od 
6 mg/kg/day 12 hourly 
I/V 
I/V 
2nd line of 
treatment 
Ceftazidime plus  
Flucloxacillin  
75-100 mg/kg/day 8 hrly 
100 mg/kg/day 6 hourly  
I/V 
I/V 
3rd line of 
treatment 
                                              Suspected Staph aureus pneumonia 
Amoxicillin plus  
Flucloxacillin (Oxacillin/ 
Nafcillin for MRSA) 
100 mg/kg/day 8 hourly 
100 mg/kg/day 6 hourly 
I/V 
I/V  
1st line of 
treatment 
Ceftriaxone plus 
Flucloxacillin 
(Clindamicin/Vancomycin for 
MRSA) 
75-100 mg/kg/day od 
100 mg/kg/day 6 hourly 
I/V 
I/V 
2nd line of 
treatment 
Vancomycin 10 mg/kg iv 8 hourly I/V 3rd line of 
treatment 
Table 2. Antimicrobial treatment of CAP 
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Heart sound (muffled or absent) 
Pulsus paradoxus   
    Enlarged liver 
 
Pneumonia in older children often present in many ways 
The following two classic presentations have been described for pneumonia (Jadavi et al., 
1997) 
 
Typical presentation (predominantly respiratory signs) 
 Fever 
 Chills 
 Pleuritic chest pain 
 Productive cough 
 Fast breathing 
 Lower chest wall indrawing 
 Cyanosis 
 
Atypical presentations (single or in combinations) gradual onset over several days to weeks: 
 Nonproductive cough 
 Low-grade fever 
 Headache 
 Malaise 
 Meningism 
 Acute abdominal pain 
 Acute pain in chest or shoulder 
 Convulsion 
 
Antibiotic use in the treatment of CAP 
When treating CAP, the clinical, laboratory and radiographic findings should be considered, 
especially when the child is hospitalized. As it is difficult to distinguish bacterial from viral 
pneumonia and because of the frequency of mixed bacterial-viral infections (≈30-40%) (Zar 
et al., 2005), all children with CAP would require an antibiotic. The age of the child, 
nutritional status, immunologic status of the host, local epidemiology of respiratory 
pathogens, and sensitivity of these pathogens to particular antimicrobial agents and the 
emergence of antimicrobial resistance usually play a big role to determine the choice of 
antibiotic therapy. The severity of pneumonia and the drug costs also have a great impact on 
the selection of antimicrobial therapy, particularly in the developing countries. The 
management of a child with CAP involves a number of decisions regarding treatment with 
antibiotics (BTS, 2002). 
 
 Whether to treat with antibiotics? 
 Which antibiotic and by which route? 
 When to change to oral treatment? 
 Total duration of antibiotic therapy; 
 When to change antibiotic and why? 
 
Outpatient management 
In children with mild pneumonia (non-severe pneumonia), the breathing is fast, but there is 
no lower chest wall indrawing. Oral antibiotics at an appropriate dose for an adequate 
duration are effective for treatment. The mother is advised to return in two days for 
reassessment, or earlier if the child appears to deteriorate. 
 
Antimicrobial agent Recommended dosage Route Comment 
                                              Neonate (0-4 weeks) 
Ampicillin plus 
Gentamicin 
100 mg/kg/day 12 hourly 
6 mg/kg/day 12 hourly 
I/V 
I/V 
1st line of 
treatment 
Ceftazidime plus  
Flucloxacillin  
75-100 mg/kg/day 8 hrly 
100 mg/kg/day 6 hourly  
I/V 
I/V 
2nd line of 
treatment 
                                              Infants > 4-8 weeks 
Ampicillin plus 
Gentamicin 
100 mg/kg/day 6 hourly 
6 mg/kg/day 12 hourly 
I/V 
I/V 
1st line of 
treatment 
Ceftriaxone plus 
Gentamicin  
75-100 mg/kg/day od 
6 mg/kg/day 12 hourly 
I/V 
I/V 
2nd line of 
treatment 
                                              Infants >8 weeks to children of 5 years plus above 5 years 
Amoxicillin 100 mg/kg/day 8 hourly Oral 1st line of 
treatment 
Azithromycin 10 mg/kg/day once daily Oral 2nd line of 
treatment 
Ceftriaxone 75-100 mg/kg/day od I/V 3rd  line of 
treatment 
                                              Severe pneumonia with SAM 
Ampicillin plus 
Gentamicin 
100 mg/kg/day 6 hourly 
6 mg/kg/day 12 hourly 
I/V 
I/V 
1st line of 
treatment 
Ceftriaxone plus 
Gentamicin  
75-100 mg/kg/day od 
6 mg/kg/day 12 hourly 
I/V 
I/V 
2nd line of 
treatment 
Ceftazidime plus  
Flucloxacillin  
75-100 mg/kg/day 8 hrly 
100 mg/kg/day 6 hourly  
I/V 
I/V 
3rd line of 
treatment 
                                              Suspected Staph aureus pneumonia 
Amoxicillin plus  
Flucloxacillin (Oxacillin/ 
Nafcillin for MRSA) 
100 mg/kg/day 8 hourly 
100 mg/kg/day 6 hourly 
I/V 
I/V  
1st line of 
treatment 
Ceftriaxone plus 
Flucloxacillin 
(Clindamicin/Vancomycin for 
MRSA) 
75-100 mg/kg/day od 
100 mg/kg/day 6 hourly 
I/V 
I/V 
2nd line of 
treatment 
Vancomycin 10 mg/kg iv 8 hourly I/V 3rd line of 
treatment 
Table 2. Antimicrobial treatment of CAP 
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                                              Suspected pseudomonas pneumonia 
Ceftazidime plus  
Ciprofloxacillin  
100 mg/kg/day 8 hrly 
20 mg/kg/day 12 hourly  
I/V 
I/V 
1st line of 
treatment 
                                              Suspected PCP pneumonia 
Co-trimoxazole (SXT) 20 mg/kg loading dose 
followed by 10 mg/kg in 2 
divided doses or, 20 
mg/kg/day in 4 divided 
doses 
Oral 1st line of 
treatment. 
Therapy to be 
continued for at 
least 14 days 
(sometimes 21 
days) 
                                              Suspected hospital acquired pneumonia 
a) For early onset HAI (if HAI occurs < 96 hours of admission) 
Fluroquinolone (e.g. 
Ciprofloxacin) plus 
aminoglycosides (e.g. 
Gentamicin) 
20 mg/kg/day in 2 
divided doses 
 
6 mg/kg/day 12 hourly 
I/V 
 
 
I/V 
1st line of 
treatment 
3rd generation cephalosporin 
e. g. Ceftriaxone Monotherapy 
with Fluroquinolone 
 
75-100 mg/kg/day od 
 
6 mg/kg/day 12 hourly 
 
I/V 
 
I/V 
2nd line of 
treatment (HAI 
where we don’t 
suspect Staph) 
3rd generation cephalosporin 
e. g. Ceftriaxone plus  
Flucloxacillin 
 
75-100 mg/kg/day od 
100 mg/kg/day 6 hourly 
 
I/V 
I/V 
3rd line of 
treatment (HAI 
where we suspect 
Staph) 
b) For late onset HAI (if HAI occurs > 96 hours of admission) 
Anti-pseudomonal penicillin 
(e. g. Ticarcillin/clavulanic 
acid) plus  
Anti-MRSA (e. g. 
Vancomycin) 
 
50 mg/kg/dose (Ticarcillin 
base: max. 3.0 gm/dose) 6 
hourly 
10 mg/kg iv 8 hourly 
 
I/V 
 
 
I/V 
1st line of 
treatment 
Anti-pseudomonal 
cephalosporin (e. g. 
Ceftazidime) plus  
Aminoglycosides with wide 
coverage (e.g. Amikacin), or 
Anti-MRSA (e. g. 
Vancomycin) 
 
 
75-100 mg/kg/day 8 hrly 
 
6 mg/kg/day 12 hourly 
10 mg/kg iv 8 hourly 
 
 
 
I/V 
 
I/V 
I/V 
2nd line of 
treatment 
 
Duration of antibiotic treatment 
Antibiotic therapy is generally recommended for 5 to 7 days for uncomplicated cases of 
childhood pneumonia (Zar et al., 2005; Mehta, 2003). For suspected Staphylococcus aureus 
infection, the duration of treatment may be extended for 14 to 21 days, depending on the 
clinical response. Gram-negative bacilli, or Legionella species, may also require longer 
courses of therapy for 10 to 21 days (BTS, 2002; Mehta, 2003). Alternatively, the newer 
macrolides such as azithromycin may be used for 3-5 days (Zar et al., 2005). In case of 
neonates, the treatment should be continued for at least 2 weeks. If pneumonia is 
complicated with empyema, the treatment should be continued for at least 4 weeks.  
 
Switching from parenteral therapy to oral therapy is a key management issue for childhood 
pneumonia. Children receiving parenteral therapy for 2 to 4 days can usually be switched to 
oral therapy provided there is clinical improvement as children becoming afebrile defined 
as the rectal temperature becoming 380 Celsius or less and remaining so for at least 24 hours 
(Ashraf et al., 2010), they can tolerate medication orally, they do not have any diarrhoea and 
vomiting and have no relevant local complications of pneumonia (Shalit et al., 1994; Dagan 
et al., 1994). Switching over to oral antibiotics will help for early discharge from the hospital 
and subsequently prevent hospital acquired infection and vacant hospital beds for other sick 
children. 
 
Indications for the use of antipyretics and analgesics in CAP 
 Rectal temperature >390 Celsius 
 There is a known risk of febrile convulsions 
 There is central nervous system pathology that may be aggravated by high fever 
 
Children with CAP are generally pyrexial and may also have some pain, including 
headache, chest pain, arthralgia (in cases of Mycoplasma pneumoniae), referred abdominal 
pain, and possibly earache from associated otitis media. Pleural pain may interfere with the 
depth of breathing and may impair the ability of the child to cough.  Antipyretics and 
analgesics can be used to keep the child comfortable and to help coughing. Minimal 
handling helps to reduce metabolic and oxygen requirements and this should be considered 
when planning and carrying out procedures, investigations, and treatments. Pain associated 
with pneumonia may be due to pleurisy or to pathology involving the upper airways. Pain 
or discomfort should be treated as it may severely compromise respiratory function and 
adequate clearance of secretions. The most appropriate agent is paracetamol at a dose of 15 
mg/kg/dose given 4-6-hourly orally or 20-40 mg/kg/dose per-rectally for two-three times 
daily. If this dose does not provide adequate analgesia, a mixture of paracetamol and 
codeine (0.5 mg/kg/dose 8-hourly) is very effective. Aspirin is contraindicated in most 
children because of the association with Reye’s syndrome (Zar et al., 2005).  
 
Calorie requirements 
Adequate nutrition is of particular concern, especially when there are underlying factors 
such as malnutrition. A minimum of 50-60 kcal/kg/day should be given to a child with 
pneumonia with continuation of regular breast feeding for breast-fed children. A calorie 
intake of 80-100 kcal/kg/day should be given to a non-breast fed child with CAP. Ensuring 
adequate calorie intake is essential as there is an excessive demand on the energy reserves in 
children with pneumonia, in whom the work of breathing is increased. Children should not 
be starved for more than 24 hours to prevent the development of hypoglycaemia. In the 
presence of malnutrition, and following several days of poor nutrition, this needs to be 
increased considerably. In the early phase of pneumonia, ketosis should be avoided by 
ensuring adequate carbohydrate intake. With time, a greater proportion of intake can be 
lipids. The intake of calories should be adequate to meet the metabolic requirements and to 
promote growth. 
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                                              Suspected pseudomonas pneumonia 
Ceftazidime plus  
Ciprofloxacillin  
100 mg/kg/day 8 hrly 
20 mg/kg/day 12 hourly  
I/V 
I/V 
1st line of 
treatment 
                                              Suspected PCP pneumonia 
Co-trimoxazole (SXT) 20 mg/kg loading dose 
followed by 10 mg/kg in 2 
divided doses or, 20 
mg/kg/day in 4 divided 
doses 
Oral 1st line of 
treatment. 
Therapy to be 
continued for at 
least 14 days 
(sometimes 21 
days) 
                                              Suspected hospital acquired pneumonia 
a) For early onset HAI (if HAI occurs < 96 hours of admission) 
Fluroquinolone (e.g. 
Ciprofloxacin) plus 
aminoglycosides (e.g. 
Gentamicin) 
20 mg/kg/day in 2 
divided doses 
 
6 mg/kg/day 12 hourly 
I/V 
 
 
I/V 
1st line of 
treatment 
3rd generation cephalosporin 
e. g. Ceftriaxone Monotherapy 
with Fluroquinolone 
 
75-100 mg/kg/day od 
 
6 mg/kg/day 12 hourly 
 
I/V 
 
I/V 
2nd line of 
treatment (HAI 
where we don’t 
suspect Staph) 
3rd generation cephalosporin 
e. g. Ceftriaxone plus  
Flucloxacillin 
 
75-100 mg/kg/day od 
100 mg/kg/day 6 hourly 
 
I/V 
I/V 
3rd line of 
treatment (HAI 
where we suspect 
Staph) 
b) For late onset HAI (if HAI occurs > 96 hours of admission) 
Anti-pseudomonal penicillin 
(e. g. Ticarcillin/clavulanic 
acid) plus  
Anti-MRSA (e. g. 
Vancomycin) 
 
50 mg/kg/dose (Ticarcillin 
base: max. 3.0 gm/dose) 6 
hourly 
10 mg/kg iv 8 hourly 
 
I/V 
 
 
I/V 
1st line of 
treatment 
Anti-pseudomonal 
cephalosporin (e. g. 
Ceftazidime) plus  
Aminoglycosides with wide 
coverage (e.g. Amikacin), or 
Anti-MRSA (e. g. 
Vancomycin) 
 
 
75-100 mg/kg/day 8 hrly 
 
6 mg/kg/day 12 hourly 
10 mg/kg iv 8 hourly 
 
 
 
I/V 
 
I/V 
I/V 
2nd line of 
treatment 
 
Duration of antibiotic treatment 
Antibiotic therapy is generally recommended for 5 to 7 days for uncomplicated cases of 
childhood pneumonia (Zar et al., 2005; Mehta, 2003). For suspected Staphylococcus aureus 
infection, the duration of treatment may be extended for 14 to 21 days, depending on the 
clinical response. Gram-negative bacilli, or Legionella species, may also require longer 
courses of therapy for 10 to 21 days (BTS, 2002; Mehta, 2003). Alternatively, the newer 
macrolides such as azithromycin may be used for 3-5 days (Zar et al., 2005). In case of 
neonates, the treatment should be continued for at least 2 weeks. If pneumonia is 
complicated with empyema, the treatment should be continued for at least 4 weeks.  
 
Switching from parenteral therapy to oral therapy is a key management issue for childhood 
pneumonia. Children receiving parenteral therapy for 2 to 4 days can usually be switched to 
oral therapy provided there is clinical improvement as children becoming afebrile defined 
as the rectal temperature becoming 380 Celsius or less and remaining so for at least 24 hours 
(Ashraf et al., 2010), they can tolerate medication orally, they do not have any diarrhoea and 
vomiting and have no relevant local complications of pneumonia (Shalit et al., 1994; Dagan 
et al., 1994). Switching over to oral antibiotics will help for early discharge from the hospital 
and subsequently prevent hospital acquired infection and vacant hospital beds for other sick 
children. 
 
Indications for the use of antipyretics and analgesics in CAP 
 Rectal temperature >390 Celsius 
 There is a known risk of febrile convulsions 
 There is central nervous system pathology that may be aggravated by high fever 
 
Children with CAP are generally pyrexial and may also have some pain, including 
headache, chest pain, arthralgia (in cases of Mycoplasma pneumoniae), referred abdominal 
pain, and possibly earache from associated otitis media. Pleural pain may interfere with the 
depth of breathing and may impair the ability of the child to cough.  Antipyretics and 
analgesics can be used to keep the child comfortable and to help coughing. Minimal 
handling helps to reduce metabolic and oxygen requirements and this should be considered 
when planning and carrying out procedures, investigations, and treatments. Pain associated 
with pneumonia may be due to pleurisy or to pathology involving the upper airways. Pain 
or discomfort should be treated as it may severely compromise respiratory function and 
adequate clearance of secretions. The most appropriate agent is paracetamol at a dose of 15 
mg/kg/dose given 4-6-hourly orally or 20-40 mg/kg/dose per-rectally for two-three times 
daily. If this dose does not provide adequate analgesia, a mixture of paracetamol and 
codeine (0.5 mg/kg/dose 8-hourly) is very effective. Aspirin is contraindicated in most 
children because of the association with Reye’s syndrome (Zar et al., 2005).  
 
Calorie requirements 
Adequate nutrition is of particular concern, especially when there are underlying factors 
such as malnutrition. A minimum of 50-60 kcal/kg/day should be given to a child with 
pneumonia with continuation of regular breast feeding for breast-fed children. A calorie 
intake of 80-100 kcal/kg/day should be given to a non-breast fed child with CAP. Ensuring 
adequate calorie intake is essential as there is an excessive demand on the energy reserves in 
children with pneumonia, in whom the work of breathing is increased. Children should not 
be starved for more than 24 hours to prevent the development of hypoglycaemia. In the 
presence of malnutrition, and following several days of poor nutrition, this needs to be 
increased considerably. In the early phase of pneumonia, ketosis should be avoided by 
ensuring adequate carbohydrate intake. With time, a greater proportion of intake can be 
lipids. The intake of calories should be adequate to meet the metabolic requirements and to 
promote growth. 
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Enteral feeds 
Children with pneumonia should be encouraged to feed orally unless there are indications 
for nasogastric feeding/intravenous fluid infusions. If children are too distressed to take 
fluid and feeds orally, continuous enteral feeds via a nasogastric tube may be provided. 
 
Indications for N/G tube feeding 
 Too distressed to drink or swallow safely 
 Having frequent severe coughing episodes that may be associated with vomiting 
and possible aspiration of gastric contents 
 Hypovolaemia with associated poor peripheral perfusion (may even require I/V 
fluid) 
 Painful oral sore/condition which interfere with feeding by mouth 
 
Fluid therapy 
Children with uncomplicated pneumonia should receive normal maintenance fluids. 
Appropriate rehydration is required in children who are dehydrated. Oral intake should 
cease when a child is in severe respiratory distress. In severe pneumonia, inappropriate 
secretion of anti-diuretic hormone (ADH) is increased (Dhawan et al., 1992), dehydration is 
therefore uncommon. It is important that the child should not be over hydrated. A study of 
264 hospitalized children with CAP in India has shown hyponatraemia on admission in 27% 
cases and it was calculated that, in 68% of these children, the hyponatraemia was secondary 
to inappropriate ADH secretion (SIADH) (Singhi & Dhawan, 1992). Treatment is with fluid 
restriction.  
 
Intravenous fluids must be used with great care and with caution, and only if adequate 
monitoring is available (Zar et al., 2005). Children who are vomiting or who are severely ill 
may require intravenous fluids. These should be given at 80% of the basal levels (once 
hypovolaemia has been corrected). In children with severe or complicated pneumonia, 
serum urea and electrolytes should be measured before instituting I/V fluids as among 
them (SIADH) is common. In these children, fluid intake should be restricted to 40-60% of 
normal requirements, i.e. 50 ml/kg/day of I/V fluids. They should be frequently monitored 
as severely ill children with CAP might develop SIADH as a recognized complication 
(Dhawan et al., 1992; Singhi & Dhawan, 1992). 
 
Indications for I/V fluid 
 Shock 
 Inability to tolerate enteral feeds 
 Sepsis 
 Severe dehydration 
 Gross electrolyte imbalance 
 Hypoglycaemia  
 
Monitoring of the child with CAP 
The following parameters should be routinely monitored in every child with CAP, the 
frequency of which will depend on the severity of illness as well as the availability of 
resources. Special attention should be given to child receiving I/V fluid therapy and those 
with SAM. 
   
 Heart rate 
 Respiratory rate 
 Temperature 
 Respiratory pattern including chest recession 
 Lower chest wall indrawing 
 Use of accessory muscles 
 Establishment of oral feeding 
 Liver size 
 Oxygen saturation level 
 Chest auscultation: rales, rhonchi, bilateral basal crepitation, pleural rub 
 Fluid and calorie intake 
 
Children on oxygen therapy should have at least 4-hourly observations of all the above 
parameters and children without getting oxygen should be observed at least 12-hourly. 
If a child remains pyrexial or unwell 48 hours after admission with pneumonia, re-
evaluation is necessary with consideration given to exclude possible local complications 
of CAP (BTS, 2002). 
 
Micronutrient supplementation 
In children with CAP, as an adjuvant therapy with antibiotics, 20 mg of Zinc po daily until 
discharge was found to accelerate the recovery from severe pneumonia, reducing the 
duration of hypoxaemia (Brooks et al., 2004; Shakur et al., 2004; Mahalanabis et al., 2002). 
Zinc should therefore be considered for use in children hospitalized with CAP, particularly 
if there is co-existing SAM. Zinc also reduces the incidence of pneumonia, especially in 
children with SAM. But, studies from Vellore, India showed that zinc has no significant role 
to reduce the morbidity and mortality in children with acute severe pneumonia (Bose et al., 
2006). Zinc should therefore be considered cautiously for use in children hospitalized with 
CAP. 
 
Non-response to therapy 
If a child remains pyrexial or unwell 48 hours after admission with CAP, re-evaluation is 
necessary with consideration given to the possible complications: 
 
 Inappropriate drug (antibiotic): in relation to choice of antibiotic, adequate 
dosage, route of administration, and duration of antibiotic therapy 
 Development of local lung complications of CAP such as pleural effusion, 
empyema, lung abscess, bronchieactasis, pneumothorax, liver abscess etc. 
 Immunosuppression 
 Coexisting disease such as cystic fibrosis, chronic suppurative bronchitis, 
congenital heart disease (CHD), Down’s Syndrome 
 Underlying SAM: slow, delayed and poor response to conventional antibiotic 
therapy 
 Underlying TB (PTB, miliary TB, disseminated TB, TBM)  
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Enteral feeds 
Children with pneumonia should be encouraged to feed orally unless there are indications 
for nasogastric feeding/intravenous fluid infusions. If children are too distressed to take 
fluid and feeds orally, continuous enteral feeds via a nasogastric tube may be provided. 
 
Indications for N/G tube feeding 
 Too distressed to drink or swallow safely 
 Having frequent severe coughing episodes that may be associated with vomiting 
and possible aspiration of gastric contents 
 Hypovolaemia with associated poor peripheral perfusion (may even require I/V 
fluid) 
 Painful oral sore/condition which interfere with feeding by mouth 
 
Fluid therapy 
Children with uncomplicated pneumonia should receive normal maintenance fluids. 
Appropriate rehydration is required in children who are dehydrated. Oral intake should 
cease when a child is in severe respiratory distress. In severe pneumonia, inappropriate 
secretion of anti-diuretic hormone (ADH) is increased (Dhawan et al., 1992), dehydration is 
therefore uncommon. It is important that the child should not be over hydrated. A study of 
264 hospitalized children with CAP in India has shown hyponatraemia on admission in 27% 
cases and it was calculated that, in 68% of these children, the hyponatraemia was secondary 
to inappropriate ADH secretion (SIADH) (Singhi & Dhawan, 1992). Treatment is with fluid 
restriction.  
 
Intravenous fluids must be used with great care and with caution, and only if adequate 
monitoring is available (Zar et al., 2005). Children who are vomiting or who are severely ill 
may require intravenous fluids. These should be given at 80% of the basal levels (once 
hypovolaemia has been corrected). In children with severe or complicated pneumonia, 
serum urea and electrolytes should be measured before instituting I/V fluids as among 
them (SIADH) is common. In these children, fluid intake should be restricted to 40-60% of 
normal requirements, i.e. 50 ml/kg/day of I/V fluids. They should be frequently monitored 
as severely ill children with CAP might develop SIADH as a recognized complication 
(Dhawan et al., 1992; Singhi & Dhawan, 1992). 
 
Indications for I/V fluid 
 Shock 
 Inability to tolerate enteral feeds 
 Sepsis 
 Severe dehydration 
 Gross electrolyte imbalance 
 Hypoglycaemia  
 
Monitoring of the child with CAP 
The following parameters should be routinely monitored in every child with CAP, the 
frequency of which will depend on the severity of illness as well as the availability of 
resources. Special attention should be given to child receiving I/V fluid therapy and those 
with SAM. 
   
 Heart rate 
 Respiratory rate 
 Temperature 
 Respiratory pattern including chest recession 
 Lower chest wall indrawing 
 Use of accessory muscles 
 Establishment of oral feeding 
 Liver size 
 Oxygen saturation level 
 Chest auscultation: rales, rhonchi, bilateral basal crepitation, pleural rub 
 Fluid and calorie intake 
 
Children on oxygen therapy should have at least 4-hourly observations of all the above 
parameters and children without getting oxygen should be observed at least 12-hourly. 
If a child remains pyrexial or unwell 48 hours after admission with pneumonia, re-
evaluation is necessary with consideration given to exclude possible local complications 
of CAP (BTS, 2002). 
 
Micronutrient supplementation 
In children with CAP, as an adjuvant therapy with antibiotics, 20 mg of Zinc po daily until 
discharge was found to accelerate the recovery from severe pneumonia, reducing the 
duration of hypoxaemia (Brooks et al., 2004; Shakur et al., 2004; Mahalanabis et al., 2002). 
Zinc should therefore be considered for use in children hospitalized with CAP, particularly 
if there is co-existing SAM. Zinc also reduces the incidence of pneumonia, especially in 
children with SAM. But, studies from Vellore, India showed that zinc has no significant role 
to reduce the morbidity and mortality in children with acute severe pneumonia (Bose et al., 
2006). Zinc should therefore be considered cautiously for use in children hospitalized with 
CAP. 
 
Non-response to therapy 
If a child remains pyrexial or unwell 48 hours after admission with CAP, re-evaluation is 
necessary with consideration given to the possible complications: 
 
 Inappropriate drug (antibiotic): in relation to choice of antibiotic, adequate 
dosage, route of administration, and duration of antibiotic therapy 
 Development of local lung complications of CAP such as pleural effusion, 
empyema, lung abscess, bronchieactasis, pneumothorax, liver abscess etc. 
 Immunosuppression 
 Coexisting disease such as cystic fibrosis, chronic suppurative bronchitis, 
congenital heart disease (CHD), Down’s Syndrome 
 Underlying SAM: slow, delayed and poor response to conventional antibiotic 
therapy 
 Underlying TB (PTB, miliary TB, disseminated TB, TBM)  
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 Underlying malignancy 
 Underlying HIV infection 
 Development of heart failure 
 Metastatic infection can rarely occur as a result of the septicaemia associated 
with CAP. Osteomyelitis or septic arthritis should be considered, particularly 
with Staph aureus infections. 
 Incorrect diagnosis of CAP 
 
Complications of CAP 
 Fortunately, most children with CAP recover without any complication 
 Persistent effusions and empyemas are the most common serious complications of 
bacterial pneumonia 
 Pulmonary abscess 
 Respiratory distress  
 Sepsis (bacteraemia may occur in 10-30% cases of pneumonia; sepsis in <10% cases 
especially in SAM)   
 Tension pneumothorax (very rare: less than 1%) 
 
Patient education 
 Parents should be cautioned to look for the signs of increasing respiratory distress, 
danger signs of very severe pneumonia, clinical signs of hypoxaemia and advised 
to seek medical attention immediately if any of these signs appear 
 Most children with CAP treated with outpatient antibiotics will be much improved 
within 48 hours after the initiation of treatment. If such improvement does not 
occur, medical attention should be sought. 
 
Medicolegal Pitfalls 
 Attempting to treat neonates and very young infants on an outpatient basis 
 Failure to recognize and treat signs of respiratory compromise, heart failure, and 
sepsis 
 Failure to recognize and treat associated SAM 
 Failure to give parents clear discharge instructions 
 
Measures of no value in the treatment of CAP 
 Chest physiotherapy: The function of chest physiotherapy is to assist the removal 
of tracheobronchial secretions resulting in an increase of gas exchange and 
reduction in work of breathing. However, trials have found no clinically 
discernible benefit or impact of chest physiotherapy on the course of illness in 
bronchiectasis, cystic fibrosis, pneumonia, bronchiolitis, asthma, acute atelectasis, 
inhaled foreign body and post extubation babies. There is no evidence to support 
the use of chest physiotherapy including postural drainage, percussion of the chest, 
or deep breathing exercises that should be routinely performed in children with 
uncomplicated CAP (Levine, 1978; Britton et al., 1985; Stapleton, 1985; Wallis & 
Prasad, 1999). There is a suggestion that physiotherapy is counterproductive, with 
patients who receive chest physiotherapy being at risk of having a longer duration 
of fever than the control group (Britton et al., 1985). In addition, there is also no 
evidence to show that physiotherapy is beneficial in the resolving stage of 
pneumonia (Wallis & Prasad, 1999). Therefore, chest physiotherapy is not 
beneficial and should NOT be routinely prescribed for children with CAP. A 
supported sitting position may help to expand the lungs and improve the 
respiratory symptoms in children with respiratory distress. Chest physiotherapy 
only works in children with pneumonia having chronic lung disease (cystic 
fibrosis, suppurative chronic lung disease, primary ciliary dyskinesia). 
 Mucolytic agents: Anti-tussive remedies are not recommended as they cause 
suppression of cough and interfere with airway clearance. Adverse effects and 
overdose have been reported. Therefore, they should not be advised in children 
with CAP. 
 Postural drainage: There is no evidence for the use of a head-down position for 
postural drainage. 
 Nebulized bronchodilators: Nebulized bronchodilators or saline do not improve 
the outcome of CAP. 
 Cortocosteroids: There is no evidence to support the use of oral or inhaled 
corticosteroids in CAP. 
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 Underlying HIV infection 
 Development of heart failure 
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 Incorrect diagnosis of CAP 
 
Complications of CAP 
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danger signs of very severe pneumonia, clinical signs of hypoxaemia and advised 
to seek medical attention immediately if any of these signs appear 
 Most children with CAP treated with outpatient antibiotics will be much improved 
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Medicolegal Pitfalls 
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 Failure to recognize and treat associated SAM 
 Failure to give parents clear discharge instructions 
 
Measures of no value in the treatment of CAP 
 Chest physiotherapy: The function of chest physiotherapy is to assist the removal 
of tracheobronchial secretions resulting in an increase of gas exchange and 
reduction in work of breathing. However, trials have found no clinically 
discernible benefit or impact of chest physiotherapy on the course of illness in 
bronchiectasis, cystic fibrosis, pneumonia, bronchiolitis, asthma, acute atelectasis, 
inhaled foreign body and post extubation babies. There is no evidence to support 
the use of chest physiotherapy including postural drainage, percussion of the chest, 
or deep breathing exercises that should be routinely performed in children with 
uncomplicated CAP (Levine, 1978; Britton et al., 1985; Stapleton, 1985; Wallis & 
Prasad, 1999). There is a suggestion that physiotherapy is counterproductive, with 
patients who receive chest physiotherapy being at risk of having a longer duration 
of fever than the control group (Britton et al., 1985). In addition, there is also no 
evidence to show that physiotherapy is beneficial in the resolving stage of 
pneumonia (Wallis & Prasad, 1999). Therefore, chest physiotherapy is not 
beneficial and should NOT be routinely prescribed for children with CAP. A 
supported sitting position may help to expand the lungs and improve the 
respiratory symptoms in children with respiratory distress. Chest physiotherapy 
only works in children with pneumonia having chronic lung disease (cystic 
fibrosis, suppurative chronic lung disease, primary ciliary dyskinesia). 
 Mucolytic agents: Anti-tussive remedies are not recommended as they cause 
suppression of cough and interfere with airway clearance. Adverse effects and 
overdose have been reported. Therefore, they should not be advised in children 
with CAP. 
 Postural drainage: There is no evidence for the use of a head-down position for 
postural drainage. 
 Nebulized bronchodilators: Nebulized bronchodilators or saline do not improve 
the outcome of CAP. 
 Cortocosteroids: There is no evidence to support the use of oral or inhaled 
corticosteroids in CAP. 
 
References 
Ahmed T, Ali M, Ullah MM et al. Mortality in severely malnourished children with 
diarrhoea and use of   a  standardised management protocol. Lancet 1999;353:1919-
22. 
Ashraf H, Ahmed T, Hossain MI, Alam NH, Mahmud R, Kamal SM, Salam MA, Fuchs GJ. 
Day-care  management of children with severe malnutrition in an urban health 
clinic in Dhaka, Bangladesh. J Trop  Pediatr 2007;53:171-8. 
Ashraf H, Jahan SA, Alam NH, Mahmud R, Kamal SM, Salam MA, Gyr N. Day-care 
management of severe and very severe pneumonia, without associated co-
morbidities such as severe malnutrition, in an urban health clinic in Dhaka, 
Bangladesh. Arch Dis Child 2008;93:490-4. 
Ashraf H, Mahmud R, Alam NH, Jahan SA, Kamal SM, Haque F, Salam MA, Gyr N. 
Randomized-controlled trial of day-care vs hospital-care management of severe 
childhood pneumonia in Bangladesh. Pediatr (in press). 
Austrian R, Gold J. Pneumococcal bacteraemia with especial reference to bacteremic 
pneumococcal    pneumonia. Ann Intern Med 1964;60:759-76. 
Bachur R, Perry H, Harper MB. Occult pneumonias: empiric chest radiographs in febrile 
children with  leukocytosis. Ann Emerg Med 1999;33:166-73. 
Bada C, Carreazo NY, Chalco JP, Huicho L. Interobserver agreement in interpreting chest X-
rays on children with acute lower respiratory tract infections and concurrent 
wheezing. Sao Paulo Medical Journal 2007;125:150-4. 
Baqui AH, Black RE, Arifeen SE, Hill K, Mitra SN, al Sabir A. Causes of childhood deaths in 
Bangladesh: results of a nationwide verbal autopsy study. Bull World Health 
Organ 1998;76:161-71. 
Berman S, McIntosh K. Selective primary health care: strategies for control of disease in the 
developing world. XXI. Acute respiratory infections. Rev Infect Dis 1985;7:674-91. 
www.intechopen.com
Health Management 84
Bose A, Coles CL, Gunavathi, John H, Moses P, Raghupathy P, Kirubakaran C, Black RE, 
Brooks WA, Santosham M. Efficacy of zinc in the treatment of severe pneumonia in 
hospitalized children <2 y old. Am J Clin Nutr 2006;83:1089-96. 
Bowton DL, Scuderi PE, Haponik EF. The incidence and effect on outcome of hypoxemia in 
hospitalized  medical patients. Am J Med 1994;97:38-46. 
British Thoracic Society Standards of Care Committee. BTS Guidelines for the Management 
of Community Acquired Pneumonia in Childhood. Thorax 2002;57:1-24. 
Britton S, Bejstedt M, Vedin L. Chest physiotherapy in primary pneumonia. BMJ (Clin Res 
Ed)  1985;290:1703-5. 
Brooks WA, Yunus M, Santosham M, et al. Zinc for severe pneumonia in very young 
children: double-blind placebo-controlled trial. Lancet 2004;363:1683-88. 
Bryce J, Boschi-Pinto C, Shibuya K, Black RE. WHO estimates of the causes of death in 
children. Lancet 2005;365:1147-52. 
Bulla A, Hitze KL. Acute respiratory infections: a review. Bull World Health Organ 
1978;56:481-98. 
Cashat-Cruz M, Morales-Aguirre JJ, Mendoza-Azpiri M. Respiratory tract infections in 
children in  developing countries. Semin Pediatr Infect Dis 2005;16:84-92.  
Caulfield LE, de Onis M, Blossner M, et al. Undernutrition as an underlying cause of child 
deaths associated with diarrhea, pneumonia, malaria, and measles. Am J Clin Nutr 
2004;80:193-8. 
Chaisupamongkollarp T, Preuthipan A, Vaicheeta S, Chantarojanasiri T, 
KongvivekkajornkijW, Suwanjutha S. Prone position in spontaneously breathing 
infants with pneumonia. Acta Paediatr 1999;88:1033-4. 
Chisti MJ, Tebruegge M, Vincente SL, Graham SM, Duke T. Pneumonia in severely 
malnourished  chidren in developing countries - mortality risk, aetiology and 
validity of WHO clinical signs: a systematic review. Trop Med Inter Health 
2009;14:1173-89. 
Chisti MJ, Salam MA, Sharifuzzaman, Pietroni MAC. Occult pneumonia: an unusual but 
perilous entity  presenting with severe malnutrition and dehydrating diarrhoea. J 
Health Popul Nutr 2009:27:808-12.   
Chisti MJ, Ahmed T, Faruque AS, Salam MA. Clinical and laboratory features of radiologic 
pneumonia in severely malnourished infants attending an urban diarrhoea 
treatment center in Bangladesh. Pediatr  Infect Dis J 2010;29:174-7. 
Comroe JH, Bothello S. The unreliability of cyanosis in the recognition of arterial anoxemia. 
Am J Med Sci 1947;214:1-9. 
Dagan R, Syrogiannopoula G, Ashkenazi S, et al. Parenteral-oral switch in the management 
of paediatric pneumonia. Drugs 1994;47:43-51. 
de Onis M, Monterio C, Clugston G. The worldwide magnitude of protein energy 
malnutrition: an overview from the WHO global database on child growth. Bull 
World Health Organ 1993;71:703-12. 
Dhawan A, Narang A, Singhi S. Hyponatraemia and the inappropriate ADH syndrome in 
pneumonia.  Ann Trop Paediatr 1992;12:455-62. 
Dobson MB. Oxygen concentrators offer cost savings for developing countries: a study 
based in Papua New Guinea. Anaesthesia 1991;146:217-9. 
Dobson M, Peel D, Khallaf N. Field trial of oxygen concentrations in upper Egypt. Lancet  
1996;347:1597-9. 
Doherty J. WHO guidelines on detecting pneumonia in children. Lancet 1991;338:1454. 
Donowitz GR, Mandell GL. Acute pneumonia. In: Mandell GL, Douglas RG, Bennet JE, 
editors. Principles and practice of infectious diseases. New York: Churchill 
Livingstone;1990:540-54. 
Duke T, Frank D, Mgone J. Hypoxaemia in children with severe pneumonia in Papua New 
Guinea. Int J  TB Lung Dis 2000;5:511-9. 
Duke T, Tamburlini G. The Paediatric Quality Care Group. Improving the quality of 
paediatric care in  peripheral hospitals in developing countries. Arch Dis Child 
2003;88:563-5. 
Duke T, Wandi F, Jonathan M, et al. Impact of improved oxygen systems on child deaths 
from  pneumonia: a multi-hospital effectiveness study in Papua New Guinea. 
Lancet 2008;372:1328-33. 
Falade AG, Tschappeler H, Greenwood BM, Mulholland EK. Use of simple clinical signs to 
predict  pneumonia in young Gambian children: the influence of malnutrition. 
Bulletin of the World Health Organization 1995;73:299-304. 
Garenne M, Ronsmans C, Campbell H. The magnitude of mortality from acute respiratory 
infections in children under 5 years in developing countries. World Health Stat Q 
1992;45:180-91. 
Graham SM, English M, Hazir T, Enarson P, Duke T. Challenges to improving case 
management of childhood pneumonia at health facilities in resource-limited 
settings. Bull World Health Organ 2008;86:349-55. 
Hall CB, Hall WJ, Speers DM. Clinical and physiological manifestations of bronchiolitis and 
pneumonia.  Outcome of respiratory syncytial virus. Am J Dis Child 1979;133:798-
802. 
Hall FM, Simon M. Occult pneumonia associated with dehydration: myth or reality. Am J 
Roentgenol  1987;148:853-4. 
Hamid M, Qazi SA, Khan MA. Clinical, nutritional and radiological features of pneumonia. 
Journal of the  Pakistan Medical Association 1996;46:95-9. 
Huq F, Rahman M, Nahar N, Alam A, Haque M, Sack DA, Butler T, Haider R. Acute lower 
respiratory  tract infection due to virus among hospitalized children in Dhaka, 
Bangladesh. Rev Infect Dis 1990:12 Suppl 8:S982-7. 
Jadavi T, Law B, Lebel MH, Kennedy WA, Gold R, Wang EEL. A practical guide for the 
diagnosis and t treatment of pediatric pneumonia. Can Med Assoc J 1997;156:S703-
S711. 
Jurban A, Tobin MJ: Reliability of pulse oximetry in titrating supplemental oxygen therapy 
in ventilator- dependent patients. Chest 1990;97:1420-5. 
Jubran A. Pulse oximetry. Crit Care 1999; 3:R11-R17. 
Klein JO. Bacterial pneumonias. In: Textbook of pediatric infectious diseases. 3rd ed. 
Philadelphia: WB  Saunders;1992:299-314. 
Korppi M, Remes S, Heiskanen-Kosma T. Serum, procalcitonin concentrations in bacterial 
pneumonia in  children: a negative result in primary healthcare settings. Pediatr 
pulmonol 2003;35:56-61. 
Levine A. Chest physiotherapy for children with pneumonia. J Am Osteopath Assoc 
1978;78:122-5. 
Loeb M, High K. The effect of malnutrition on risk and outcome of community-acquired 
pneumonia.  Respiratory Care Clinics of North America 2005;11:99-108. 
www.intechopen.com
Treatment of childhood pneumonia in developing countries 85
Bose A, Coles CL, Gunavathi, John H, Moses P, Raghupathy P, Kirubakaran C, Black RE, 
Brooks WA, Santosham M. Efficacy of zinc in the treatment of severe pneumonia in 
hospitalized children <2 y old. Am J Clin Nutr 2006;83:1089-96. 
Bowton DL, Scuderi PE, Haponik EF. The incidence and effect on outcome of hypoxemia in 
hospitalized  medical patients. Am J Med 1994;97:38-46. 
British Thoracic Society Standards of Care Committee. BTS Guidelines for the Management 
of Community Acquired Pneumonia in Childhood. Thorax 2002;57:1-24. 
Britton S, Bejstedt M, Vedin L. Chest physiotherapy in primary pneumonia. BMJ (Clin Res 
Ed)  1985;290:1703-5. 
Brooks WA, Yunus M, Santosham M, et al. Zinc for severe pneumonia in very young 
children: double-blind placebo-controlled trial. Lancet 2004;363:1683-88. 
Bryce J, Boschi-Pinto C, Shibuya K, Black RE. WHO estimates of the causes of death in 
children. Lancet 2005;365:1147-52. 
Bulla A, Hitze KL. Acute respiratory infections: a review. Bull World Health Organ 
1978;56:481-98. 
Cashat-Cruz M, Morales-Aguirre JJ, Mendoza-Azpiri M. Respiratory tract infections in 
children in  developing countries. Semin Pediatr Infect Dis 2005;16:84-92.  
Caulfield LE, de Onis M, Blossner M, et al. Undernutrition as an underlying cause of child 
deaths associated with diarrhea, pneumonia, malaria, and measles. Am J Clin Nutr 
2004;80:193-8. 
Chaisupamongkollarp T, Preuthipan A, Vaicheeta S, Chantarojanasiri T, 
KongvivekkajornkijW, Suwanjutha S. Prone position in spontaneously breathing 
infants with pneumonia. Acta Paediatr 1999;88:1033-4. 
Chisti MJ, Tebruegge M, Vincente SL, Graham SM, Duke T. Pneumonia in severely 
malnourished  chidren in developing countries - mortality risk, aetiology and 
validity of WHO clinical signs: a systematic review. Trop Med Inter Health 
2009;14:1173-89. 
Chisti MJ, Salam MA, Sharifuzzaman, Pietroni MAC. Occult pneumonia: an unusual but 
perilous entity  presenting with severe malnutrition and dehydrating diarrhoea. J 
Health Popul Nutr 2009:27:808-12.   
Chisti MJ, Ahmed T, Faruque AS, Salam MA. Clinical and laboratory features of radiologic 
pneumonia in severely malnourished infants attending an urban diarrhoea 
treatment center in Bangladesh. Pediatr  Infect Dis J 2010;29:174-7. 
Comroe JH, Bothello S. The unreliability of cyanosis in the recognition of arterial anoxemia. 
Am J Med Sci 1947;214:1-9. 
Dagan R, Syrogiannopoula G, Ashkenazi S, et al. Parenteral-oral switch in the management 
of paediatric pneumonia. Drugs 1994;47:43-51. 
de Onis M, Monterio C, Clugston G. The worldwide magnitude of protein energy 
malnutrition: an overview from the WHO global database on child growth. Bull 
World Health Organ 1993;71:703-12. 
Dhawan A, Narang A, Singhi S. Hyponatraemia and the inappropriate ADH syndrome in 
pneumonia.  Ann Trop Paediatr 1992;12:455-62. 
Dobson MB. Oxygen concentrators offer cost savings for developing countries: a study 
based in Papua New Guinea. Anaesthesia 1991;146:217-9. 
Dobson M, Peel D, Khallaf N. Field trial of oxygen concentrations in upper Egypt. Lancet  
1996;347:1597-9. 
Doherty J. WHO guidelines on detecting pneumonia in children. Lancet 1991;338:1454. 
Donowitz GR, Mandell GL. Acute pneumonia. In: Mandell GL, Douglas RG, Bennet JE, 
editors. Principles and practice of infectious diseases. New York: Churchill 
Livingstone;1990:540-54. 
Duke T, Frank D, Mgone J. Hypoxaemia in children with severe pneumonia in Papua New 
Guinea. Int J  TB Lung Dis 2000;5:511-9. 
Duke T, Tamburlini G. The Paediatric Quality Care Group. Improving the quality of 
paediatric care in  peripheral hospitals in developing countries. Arch Dis Child 
2003;88:563-5. 
Duke T, Wandi F, Jonathan M, et al. Impact of improved oxygen systems on child deaths 
from  pneumonia: a multi-hospital effectiveness study in Papua New Guinea. 
Lancet 2008;372:1328-33. 
Falade AG, Tschappeler H, Greenwood BM, Mulholland EK. Use of simple clinical signs to 
predict  pneumonia in young Gambian children: the influence of malnutrition. 
Bulletin of the World Health Organization 1995;73:299-304. 
Garenne M, Ronsmans C, Campbell H. The magnitude of mortality from acute respiratory 
infections in children under 5 years in developing countries. World Health Stat Q 
1992;45:180-91. 
Graham SM, English M, Hazir T, Enarson P, Duke T. Challenges to improving case 
management of childhood pneumonia at health facilities in resource-limited 
settings. Bull World Health Organ 2008;86:349-55. 
Hall CB, Hall WJ, Speers DM. Clinical and physiological manifestations of bronchiolitis and 
pneumonia.  Outcome of respiratory syncytial virus. Am J Dis Child 1979;133:798-
802. 
Hall FM, Simon M. Occult pneumonia associated with dehydration: myth or reality. Am J 
Roentgenol  1987;148:853-4. 
Hamid M, Qazi SA, Khan MA. Clinical, nutritional and radiological features of pneumonia. 
Journal of the  Pakistan Medical Association 1996;46:95-9. 
Huq F, Rahman M, Nahar N, Alam A, Haque M, Sack DA, Butler T, Haider R. Acute lower 
respiratory  tract infection due to virus among hospitalized children in Dhaka, 
Bangladesh. Rev Infect Dis 1990:12 Suppl 8:S982-7. 
Jadavi T, Law B, Lebel MH, Kennedy WA, Gold R, Wang EEL. A practical guide for the 
diagnosis and t treatment of pediatric pneumonia. Can Med Assoc J 1997;156:S703-
S711. 
Jurban A, Tobin MJ: Reliability of pulse oximetry in titrating supplemental oxygen therapy 
in ventilator- dependent patients. Chest 1990;97:1420-5. 
Jubran A. Pulse oximetry. Crit Care 1999; 3:R11-R17. 
Klein JO. Bacterial pneumonias. In: Textbook of pediatric infectious diseases. 3rd ed. 
Philadelphia: WB  Saunders;1992:299-314. 
Korppi M, Remes S, Heiskanen-Kosma T. Serum, procalcitonin concentrations in bacterial 
pneumonia in  children: a negative result in primary healthcare settings. Pediatr 
pulmonol 2003;35:56-61. 
Levine A. Chest physiotherapy for children with pneumonia. J Am Osteopath Assoc 
1978;78:122-5. 
Loeb M, High K. The effect of malnutrition on risk and outcome of community-acquired 
pneumonia.  Respiratory Care Clinics of North America 2005;11:99-108. 
www.intechopen.com
Health Management 86
Lozano JM, Steinhoff M, Ruiz JG, Mesa ML, Martinez N, Dussan B. Clinical predictors of 
acute  radiological pneumonia and hypoxaemia at high altitude. Arch Dis Child 
1994;71:323-27. 
Mahalanabis D, Chowdhury A, Jana S, et al. Zinc supplementation as adjunct therapy in 
children with  measles accompanied by pneumonia: a double-blind randomized 
controlled trial. A J Clin Nutr 2002;76:604-7. 
Marks MI, Klein JO. Bacterial infections of the respiratory tract. In: Feigin RD, Cherry JD, 
editors.  Infectious diseases of the fetus and newborn infant. 4th ed. Philadelphia: 
WB Saunders;1995:891-908. 
Matai S, Peel D, Jonathan M, Wandi F, Subhi R, Duke T. Implementing an oxygen 
programme in  hospitals in Papua New Guinea. Ann Trop Paediatr 2008;28:71-8. 
Mehta PN. Choosing antibiotics for community acquired pneumonia. Indian Pediatr 
2003;40:958-64. 
Mulholland K. Magnitude of the problem of childhood pneumonia. Lancet 1999;354:590-2.  
Murphy CG, van de Pol AC, Harper MB, Bachur RG. Clinical predictors of occult 
pneumonia in the  febrile child. Acad Emer Med 2007;14:243-9. 
Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of 
Disease Study. Lancet 1997;349:1269-76. 
Nohynek H, Valkeila E, Leinonen M, et al. Erythrocyte sedimentation rate, white blood cell 
count and  serum C-reactive protein in assessing etiologic diagnosis of acute lower 
respiratory infections in children. Pediatr Infect dis J 1995;14:484-90. 
Nannan N, Norman R, Hendricks M, Dhansay MA, Bradshaw D. Estimating the burden of 
disease  attributable to childhood and maternal undernutrition in South Africa in 
2000. South African Medical Journal 2007;97:733-9. 
Onyango FE, Steinhoff MC, Wafula EM, Wariua S, Musia J, Kitonyi J. Hypoxaemia in young 
Kenyan  children with acute lower respiratory infection. BMJ 1993;306:612-5. 
Pauls S, Kruger S, Richter K, et al. Interobserver agreement in the assessment of pulmonary 
infiltrates on  chest radiography in community-acquired pneumonia. Rofo-
Fortschritte auf dem Gebieta der  Rontgenstrahlen und der Nuklearmedinn 
2007;79;1152-8. 
Rahman M, Huq F, Sack DA, Butler T, Azad AK, Alam A, Nahar N, Islam M. Acute lower 
respiratory tract infections in hospitalized patients with diarrhea in Dhaka, 
Bangladesh. Rev Infect Dis 1990:12 Suppl 8:S899-906. 
Rice AL, Sacco L, Hyder A, Black RE. Malnutrition as an underlying cause of childhood 
deaths  associated with infectious diseases in developing countries. Bull World 
Health Organ 2000;78:1207-21. 
Riley I, Carrad E, Gratten H, et al. The status of research in acute respiratory infections in 
children in  Papua New Guinea. Pediatr Res 1983;17:1041-3. 
Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H, WHO Child Health Epidemiology 
Reference Group. Global estimate of the incidence of clinical pneumonia among 
children under five years of age. Bull World Health Organ 2004;82:895-903. 
Rudan R, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and 
etiology of childhood pneumonia. Bull World Health Organ 2008;86:408-16. 
Sarria E, Fisher GB, Lima JA, Menna Barreto SS, Flores JA, Sukiennik R. Interobserver 
agreement in the  radiological diagnosis of lower respiratory tract infections in 
children. J Pediatr (Rio J) 2003;79:497-503. 
Sazawal S, Black RE. Pneumonia Case Management Trials Group. Effect of pneumonia case 
management on mortality in neonates, infants, and preschool children: a meta-
analysis of community-based trials. Lancet Infect Dis 2003;3:547-56.  
Selwyn BJ. The epidemiology of acute respiratory infection in young children: comparison 
of findings  from several developing countries. Rev Infect Dis 1990;12:Suppl 8:S870-
S888. 
Shakur MS, Malek MA, Bano N, Islam K. Zinc status in well nourished Bangladeshi children 
suffering  from acute lower respiratory infection. Indian J Pediatr 2004;41:478-81. 
Shalit I, Dagan R, Engelhard D, et al. Cefuroxime efficacy in pneumonia: sequential short 
course i.v./oral  suspension therapy. Isr J Med Sci 1994;30:684-9. 
Shann F, Barker J, Poore P. Clinical signs that predict death in children with severe 
pneumonia. Pediatr  Infect Dis J 1989;8:852-5. 
Shimeles D, Lulseged S. Clinical profile and pattern of infection in Ethiopian children with 
severe  protein-energy malnutrition. East African Medical Journal 1994;71:749-67. 
Singhi S, Dhawan A. Frequency and significance of electrolyte abnormalities in pneumonia. 
Indian  Pediatr 1992;29:735-40. 
Stapleton T. Chest physiotherapy in primary pneumonia. BMJ 1985;291:143. 
Steinhoff M, Black R. Childhood pneumonia: we must move forward. Lancet 2007;369:1409-
10. 
Subhi R, Adamson M, Campbell H, Weber M, Smith K, Duke T, et al. The prevalence of 
hypoxaemia  among ill children in developing countries: a systematic review. 
Lancet Infect Dis 2009;9:219-27. 
Suskind D, Murthy KK, Suskind RM. The malnourished child: an overview. In: Suskind RM, 
Lewinter- Suskind L, editors. The malnourished child. New York, NY: 
Vevey/Raven Press, 1990:1-22. 
Swingler GH, Hussey GD, Zwarenstein M. Randomised controlled trial of clinical outcome 
after chest  radiograph in ambulatory acute lower respiratory infection in children. 
Lancet 1998;351:404-8. 
Swingler GH. Radiologic differentiation between bacterial and viral lower respiratory 
infection in  children: a systematic literature review. Clin Pediatr 2000;39:627-33. 
Swingler GH. Observer variation in chest radiography of acute lower respiratory infections 
in children: a  systematic review. BMC Medical Imaging 2001;1:1. 
Toikka P, Irjala K, Juven T, et al. Serum procalcitonin, C-reactive protein and interleukin-6 
for  distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 
2000;19:598-602. 
UN General Assembly. United Nations Millennium Declaration. New York: United Nations, 
2000. http://www.un.org/millennium/declaration/ares552e.pdf (accessed March 
2, 2009). 
UNICEF & World Health Organization. Pneumonia: the forgotten killer of children. New 
York: UNICEF/WHO, 2006 
Wafula EM, Ngamau DW, Onyango FE, Mirza NM, Njeru EK. X-ray diagnosable 
pneumonia in children  with severe malnutrition at Kenyatta National Hospital. 
East African Medical Journal 1998;75:567-71. 
Walley J, Lawn J, Tinker A, et al. Primary health care: making Alma-Ata a reality. Lancet 
2008;372:1001-7. 
www.intechopen.com
Treatment of childhood pneumonia in developing countries 87
Lozano JM, Steinhoff M, Ruiz JG, Mesa ML, Martinez N, Dussan B. Clinical predictors of 
acute  radiological pneumonia and hypoxaemia at high altitude. Arch Dis Child 
1994;71:323-27. 
Mahalanabis D, Chowdhury A, Jana S, et al. Zinc supplementation as adjunct therapy in 
children with  measles accompanied by pneumonia: a double-blind randomized 
controlled trial. A J Clin Nutr 2002;76:604-7. 
Marks MI, Klein JO. Bacterial infections of the respiratory tract. In: Feigin RD, Cherry JD, 
editors.  Infectious diseases of the fetus and newborn infant. 4th ed. Philadelphia: 
WB Saunders;1995:891-908. 
Matai S, Peel D, Jonathan M, Wandi F, Subhi R, Duke T. Implementing an oxygen 
programme in  hospitals in Papua New Guinea. Ann Trop Paediatr 2008;28:71-8. 
Mehta PN. Choosing antibiotics for community acquired pneumonia. Indian Pediatr 
2003;40:958-64. 
Mulholland K. Magnitude of the problem of childhood pneumonia. Lancet 1999;354:590-2.  
Murphy CG, van de Pol AC, Harper MB, Bachur RG. Clinical predictors of occult 
pneumonia in the  febrile child. Acad Emer Med 2007;14:243-9. 
Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of 
Disease Study. Lancet 1997;349:1269-76. 
Nohynek H, Valkeila E, Leinonen M, et al. Erythrocyte sedimentation rate, white blood cell 
count and  serum C-reactive protein in assessing etiologic diagnosis of acute lower 
respiratory infections in children. Pediatr Infect dis J 1995;14:484-90. 
Nannan N, Norman R, Hendricks M, Dhansay MA, Bradshaw D. Estimating the burden of 
disease  attributable to childhood and maternal undernutrition in South Africa in 
2000. South African Medical Journal 2007;97:733-9. 
Onyango FE, Steinhoff MC, Wafula EM, Wariua S, Musia J, Kitonyi J. Hypoxaemia in young 
Kenyan  children with acute lower respiratory infection. BMJ 1993;306:612-5. 
Pauls S, Kruger S, Richter K, et al. Interobserver agreement in the assessment of pulmonary 
infiltrates on  chest radiography in community-acquired pneumonia. Rofo-
Fortschritte auf dem Gebieta der  Rontgenstrahlen und der Nuklearmedinn 
2007;79;1152-8. 
Rahman M, Huq F, Sack DA, Butler T, Azad AK, Alam A, Nahar N, Islam M. Acute lower 
respiratory tract infections in hospitalized patients with diarrhea in Dhaka, 
Bangladesh. Rev Infect Dis 1990:12 Suppl 8:S899-906. 
Rice AL, Sacco L, Hyder A, Black RE. Malnutrition as an underlying cause of childhood 
deaths  associated with infectious diseases in developing countries. Bull World 
Health Organ 2000;78:1207-21. 
Riley I, Carrad E, Gratten H, et al. The status of research in acute respiratory infections in 
children in  Papua New Guinea. Pediatr Res 1983;17:1041-3. 
Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H, WHO Child Health Epidemiology 
Reference Group. Global estimate of the incidence of clinical pneumonia among 
children under five years of age. Bull World Health Organ 2004;82:895-903. 
Rudan R, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and 
etiology of childhood pneumonia. Bull World Health Organ 2008;86:408-16. 
Sarria E, Fisher GB, Lima JA, Menna Barreto SS, Flores JA, Sukiennik R. Interobserver 
agreement in the  radiological diagnosis of lower respiratory tract infections in 
children. J Pediatr (Rio J) 2003;79:497-503. 
Sazawal S, Black RE. Pneumonia Case Management Trials Group. Effect of pneumonia case 
management on mortality in neonates, infants, and preschool children: a meta-
analysis of community-based trials. Lancet Infect Dis 2003;3:547-56.  
Selwyn BJ. The epidemiology of acute respiratory infection in young children: comparison 
of findings  from several developing countries. Rev Infect Dis 1990;12:Suppl 8:S870-
S888. 
Shakur MS, Malek MA, Bano N, Islam K. Zinc status in well nourished Bangladeshi children 
suffering  from acute lower respiratory infection. Indian J Pediatr 2004;41:478-81. 
Shalit I, Dagan R, Engelhard D, et al. Cefuroxime efficacy in pneumonia: sequential short 
course i.v./oral  suspension therapy. Isr J Med Sci 1994;30:684-9. 
Shann F, Barker J, Poore P. Clinical signs that predict death in children with severe 
pneumonia. Pediatr  Infect Dis J 1989;8:852-5. 
Shimeles D, Lulseged S. Clinical profile and pattern of infection in Ethiopian children with 
severe  protein-energy malnutrition. East African Medical Journal 1994;71:749-67. 
Singhi S, Dhawan A. Frequency and significance of electrolyte abnormalities in pneumonia. 
Indian  Pediatr 1992;29:735-40. 
Stapleton T. Chest physiotherapy in primary pneumonia. BMJ 1985;291:143. 
Steinhoff M, Black R. Childhood pneumonia: we must move forward. Lancet 2007;369:1409-
10. 
Subhi R, Adamson M, Campbell H, Weber M, Smith K, Duke T, et al. The prevalence of 
hypoxaemia  among ill children in developing countries: a systematic review. 
Lancet Infect Dis 2009;9:219-27. 
Suskind D, Murthy KK, Suskind RM. The malnourished child: an overview. In: Suskind RM, 
Lewinter- Suskind L, editors. The malnourished child. New York, NY: 
Vevey/Raven Press, 1990:1-22. 
Swingler GH, Hussey GD, Zwarenstein M. Randomised controlled trial of clinical outcome 
after chest  radiograph in ambulatory acute lower respiratory infection in children. 
Lancet 1998;351:404-8. 
Swingler GH. Radiologic differentiation between bacterial and viral lower respiratory 
infection in  children: a systematic literature review. Clin Pediatr 2000;39:627-33. 
Swingler GH. Observer variation in chest radiography of acute lower respiratory infections 
in children: a  systematic review. BMC Medical Imaging 2001;1:1. 
Toikka P, Irjala K, Juven T, et al. Serum procalcitonin, C-reactive protein and interleukin-6 
for  distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 
2000;19:598-602. 
UN General Assembly. United Nations Millennium Declaration. New York: United Nations, 
2000. http://www.un.org/millennium/declaration/ares552e.pdf (accessed March 
2, 2009). 
UNICEF & World Health Organization. Pneumonia: the forgotten killer of children. New 
York: UNICEF/WHO, 2006 
Wafula EM, Ngamau DW, Onyango FE, Mirza NM, Njeru EK. X-ray diagnosable 
pneumonia in children  with severe malnutrition at Kenyatta National Hospital. 
East African Medical Journal 1998;75:567-71. 
Walley J, Lawn J, Tinker A, et al. Primary health care: making Alma-Ata a reality. Lancet 
2008;372:1001-7. 
www.intechopen.com
Health Management 88
Wallis C, Prasad A. Who needs chest physiotherapy? Moving from anecdote to evidence. 
Arch Dis Child  1999;80:393-7. 
Wang EFL, Law BJ, Stephens D, PICNIC. Pediatric Investigators Collaborative Network on 
Infections in Canada (PICNIC) study of morbidity and mortality risk factors with 
RSV disease. J Pediatr 1995;126:212-9. 
Wardlaw TM, Johansson EW, Hodge M, WHO, UNICEF. Pneumonia: the forgotten killer of 
children. Geneva: World Health Organization, 2006. 
Weber MW, Usen S, Palmer A, Jaffar S, Mulholland EK. Predictors of hypoxaemia in 
hospital  admissions with acute lower respiratory tract infection in a developing 
country. Arch Dis Child 1997;76:310-4. 
Weber MW, Mulholland EK. Pulse oximetry in developing countries. Lancet 1998;351:1589. 
Williams BG, Gouws E, Boschi-Pinto C, Bryce J, Dye C. Estimates of world-wide distribution 
of child deaths from acute respiratory infections. Lancet Infect Dis 2002;2:25-32. 
World Health Organization. A programme for controlling acute respiratory infections in 
children:  memorandum from a WHO meeting. Bull World Health Organ 1984; 
62:47-58.  
World Health Organization. Acute respiratory infections in children: case management in 
small hospitals  in developing countries. A manual for doctors and other senior 
health workers. WHO/ARI/ 90.5. Geneva: WHO, 1990.  
World Health Organization. Management of the young child with an acute respiratory 
infection.  Programme for control of acute respiratory infections. Geneva: WHO, 
1991.  
World Health Organization. Technical basis for the WHO recommendations on the 
management of pneumonia in children at first-level health facilities 
(WHO/ARI/91.20). Geneva: WHO, 1991. 
World Health Organization. Life in the 21st century. A vision for all. Geneva: WHO, 1998:66. 
World Health Organization. Management of the child with a serious infection or severe 
malnutrition  Guidelines for care at the first-referral level in developing countries 
(WHO/FCH/CAH/00.1). Geneva: WHO, 2000.  
World Health Organization. WHO Pocket book of hospital care for children: Guidelines for 
the  management of common illness with limited resources. Geneva: WHO, 2005. 
World Health Organization. The clinical use of oxygen in hospitals with limited resources. 
Guidelines for health-care workers, hospital engineers and managers. Editor: Duke 
T; Geneva: WHO, 2009. 
Zar HJ, Jeena P, Argent A, Gie R, Madhi SA. Diagnosis and management of community-
acquired  pneumonia in childhood- South African Thoracic Society Guidelines. S 
Afr Med J 2005;95:977-90. 
 
www.intechopen.com
Health Management
Edited by Krzysztof Smigorski
ISBN 978-953-307-120-6
Hard cover, 112 pages
Publisher Sciyo
Published online 27, September, 2010
Published in print edition September, 2010
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Possibilities of medical intervention have thrived over the last decades. Our knowledge about mechanisms of
the development of diseases and factors influencing it has increased. Effective treatment requires a holistic
approach that takes into consideration aspects at first sight not related to a course of a specific disorder. This
book contains a few chapters focusing on issues related to health management. The chapters are arranged in
an order reflecting multidimensionality of issues constituting this theoretical and practical area - starting from
the studies focusing on a general, administrative level, to considerations related to situations of individuals
suffering from a specific illness. The discussed problems concern different age groups - children, adults and
the elderly. We hope that readers professionally engaged in healthcare - both theoretically and clinically - will
find it interesting, useful and inspiring.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Hasan Ashraf, Mohammud Jobayer Chisti and Nur Haque Alam (2010). Treatment of Childhood Pneumonia in
Developing Countries, Health Management, Krzysztof Smigorski (Ed.), ISBN: 978-953-307-120-6, InTech,
Available from: http://www.intechopen.com/books/health-management/treatment-of-childhood-pneumonia-in-
developing-countries
© 2010 The Author(s). Licensee IntechOpen. This chapter is distributed
under the terms of the Creative Commons Attribution-NonCommercial-
ShareAlike-3.0 License, which permits use, distribution and reproduction for
non-commercial purposes, provided the original is properly cited and
derivative works building on this content are distributed under the same
license.
